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ABSTRACT 
 
 
Influenza A viruses are capable of causing disease in several species, including 
birds, humans and swine.  Host specificity of the viruses is not absolute, and is influenced 
by a range of factors.  Swine play a pivotal role in the interspecies transmission of 
influenza A viruses, as they are susceptible to infection with both human and avian 
strains and have been implicated as a “mixing vessel” for the reassortment of influenza A 
viruses from different species.  The reassortment of influenza A viruses of human and 
avian origin led to human influenza pandemics in 1957 and 1968. 
 
The dynamics of swine influenza viruses in North America changed drastically 
with the introduction of the avian-origin PA and PB2 and human-origin HA, NA, and 
PB1 gene segments and the creation of the triple reassortant swine virus lineage in 1998.  
While the previously circulating classical swine H1N1 influenza virus lineage was very 
stable in the swine population, triple reassortant lineage viruses have supplanted the 
classical H1N1 lineage and undergone repeated reassortment events, acquiring HA and 
NA genes from human, swine, and avian influenza viruses, while maintaining triple 
reassortant internal gene (TRIG) cassette.  Viruses of the triple reassortant lineage have 
been very successful in the swine population, yet the mechanisms underlying their unique 
characteristics and increased fitness have not been elucidated. 
 
Here we address the pandemic potential of triple reassortant swine influenza A 
viruses, their transmissibility, and their relative fitness compared to classical and double 
reassortant swine influenza viruses.  Several triple reassortant viruses, including one with 
avian-origin HA and NA, were characterized in the ferret, which is a commonly used 
model for human influenza infection.  The effect of the TRIG cassette on the 
reassortment potential and temperature sensitivity of swine influenza viruses was 
determined in cell culture, and the replication and transmission of a classical and a 
reassortant swine virus were compared in pigs. 
 
We found that triple reassortant swine viruses replicated efficiently in the ferret 
model, although there was some variation in transmission efficiencies.  An H2N3 virus 
with avian-origin HA and NA was transmissible in the ferret model, and this 
transmissibility could be abolished with a single amino acid change in the HA protein 
that altered its receptor binding specificity.  Avian H2N3 viruses were also capable of 
replicating in ferrets without adaptation and could acquire transmissibility through a 
change in the receptor binding specificity of the HA protein. 
 
Both double and triple reassortant swine viruses had an advantage over the 
classical H1N1 swine virus at early timepoints in cell culture.  Reassortant viruses also 
demonstrated less temperature sensitivity than the classical H1N1 swine virus.  The triple 
reassortant H1N1 virus had an increased reassortment potential in cell culture compared 
to the classical swine H1N1 virus as determined by acquisition of a human HA gene.   
 
 
 
vi 
Triple reassortant swine viruses have an increased ability to establish infection, 
and an increased potential for reassortment, potentially introducing novel HA genes into 
a host population.  This indicates that triple reassortant swine viruses may have an 
increased potential to cause human pandemics.  In April 2009, a novel H1N1 pandemic 
virus containing five of the six genes of the TRIG cassette emerged in the human 
population, emphasizing the importance of reassortant swine influenza A viruses in the 
generation of human pandemics. 
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CHAPTER 1: INTRODUCTION 
 
 
Virus Classification 
 
Influenza A viruses are a genus of the family Orthomyxoviridae, along with 
Influenza B virus, Influenza C virus, Isavirus, and Thogotovirus (62).  Influenza A, B, 
and C viruses are differentiated from each other based on antigenic differences in their 
nucleoprotein (NP) and matrix (M1) proteins (150), and influenza A viruses are further 
classified into subtypes based on their two surface glycoproteins, hemagglutinin (HA) 
and neuraminidase (NA).  There have been 16 HA and 9 NA subtypes identified based on 
the antigenic properties of these proteins (39,151). 
 
 
Virus Structure and Replication 
 
Influenza A viruses are enveloped viruses with a segmented genome that is 
comprised of eight negative-sense, single-stranded RNA molecules (Figure 1-1).  These 8 
segments encode 11 proteins.  The polymerase complex is comprised of three proteins, 
PB2, PB1, and PA (7), that along with a viral RNA (vRNA) segment and the NP protein 
form the viral ribonucleoprotein (vRNP) complex (27).  In the viral particle, the vRNPs 
are associated with the M1 protein, which is the main structural protein of influenza A 
viruses and lies just below the lipid envelope.  There are two surface glycoproteins 
anchored in the envelope, HA and NA.  HA serves as the receptor binding and fusion 
protein for influenza A viruses, as well as being its major antigenic protein.  NA is a 
sialidase and acts to cleave cell surface sialic acids to allow for viral release.  Also 
contained within the viral envelope is the matrix protein 2 (M2).  This protein forms an 
envelope-spanning proton channel (109) which allows for acidification of the viral 
particle and the dissociation of the vRNPs from M1 for release into the cell cytoplasm 
(72).  The genome also encodes two non-structural proteins (NS1 and NS2) as well as an 
alternate reading frame protein from PB1 known as PB1-F2 (22).  NS1 has several 
functions in the infected cell, including binding double-stranded RNA (102), and 
suppressing an infected cell’s type I interferon response (43) and protein kinase R 
response (6).  NS2 is involved in the nuclear export of newly-synthesized vRNP 
complexes (103), while PB1-F2 induces cell apoptosis as well as enhancing the 
development of secondary bacterial pneumonia (93). 
 
Viral infection of a cell begins when the HA proteins on the surface of an 
influenza A virus particle bind with α-2,3 or α-2,6 linked terminal sialyloligosaccharides 
on the surface of an epithelial cell.  This causes the virus to be endocytosed (91) and 
acidification of the endosome leads to a conformational change in the HA protein that 
exposes the fusion peptide.  The insertion of the fusion peptides of several HA molecules 
into the endocytic membrane forms a pore that allows for the release of the vRNPs from 
the virus particle into the cytoplasm of the cell (32).  The vRNPs are transported into the 
nucleus of the cell where the vRNA serves as a template for the synthesis of both  
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Figure 1-1.  Schematic of the Influenza A Virus Particle.  Influenza A virus particles 
contain eight single-stranded RNA gene segments and have two surface glycoproteins – 
HA, shown in purple, and NA, shown in pink.  Reprinted with permission from R.G. 
Webster. 
 
 
3 
messenger RNA (mRNA) and full-length complementary RNA (cRNA) molecules.  The 
mRNA molecules are translated into new viral proteins, and the cRNA molecules are 
used as templates for the synthesis of new vRNA molecules. 
 
The three subunits of the influenza A polymerase complex (PB2, PB1, and PA) 
catalyze the synthesis of all viral RNA products.  The initiation of mRNA synthesis 
requires a 5’ capped primer, which the virus obtains from host cell pre-mRNA transcripts 
(68).  PB1 binds to the 5’ end of the vRNA, which allows the capped primer to be bound 
by PB2 and cleaved by PB1 (77).  Elongation is catalyzed by PB1 and continues until the 
polymerase complex reaches a stretch of uridine residues near the 5’ end of the vRNA.  
These nucleotides, along with the secondary structure of the vRNA, cause the polymerase 
to stutter, adding a poly-adenosine tail to the transcript (111).  Following the transcription 
and translation of the mRNAs, the viral polymerase complex switches from transcription 
to replication.  There are several theories as to the mechanism responsible for the switch 
from transcription to replication.  The presence of newly-synthesized NP proteins has 
been shown to be necessary (123), but it is not known if these proteins induce a 
conformational change in the polymerase complex, thereby changing its activity, or if 
they associate with cRNA molecules to prevent their degradation and allow transcription 
to vRNA (110).  It has also been suggested that the viral polymerase complex is 
synthesizes mRNA and cRNA simultaneously, but that the cRNA molecules are degraded 
in the absence of newly-synthesized polymerase complexes (144). 
 
During replication, a positive-sense cRNA molecule is first synthesized for each 
gene segment and then used as a template for the negative-sense viral genome.  Unlike 
mRNA synthesis, cRNA and vRNA synthesis do not require 5’ capped primers and result 
in full-length transcripts (69).  Following the replication of the viral genome, vRNP 
complexes are formed in the nucleus and exported to the cytoplasm through interactions 
with M1, NS2 and cellular chaperones (37,103,12).  After nuclear export, the vRNPs are 
transported to areas of the lipid membrane with high concentrations of HA and NA.  
There are two proposed models for the packaging of vRNPs into virus particles, random 
incorporation and selective incorporation.  The random incorporation model assumes that 
a common feature present on al vRNPs causes them to be incorporated into newly 
forming virions (3).  The selective incorporation model proposes that each gene segment 
has a unique packaging signal that allows for the selective packaging of one of each 
vRNP that comprises the influenza A genome (35).  Conserved sequences at the 3’ and 5’ 
coding regions of PB2, PB1, PA (79), HA (146), NA (41), and NS (40) have all been 
demonstrated to be necessary for efficient incorporation of vRNPs into viral particles.  
While there is increasing evidence to support the selective incorporation model, the exact 
mechanism controlling segment specific packaging is not understood.  However, it most 
likely involves interactions between the packaging sequences of each vRNA or 
interactions between the packaging signals and viral proteins.   
 
Following genome packaging, new virus particles are formed by budding of the 
lipid membrane.  NA is responsible for cleaving cell surface sialic acids to allow the 
newly-budded virus to be released (81).  Once released, HA molecules, which are 
synthesized as an HA0 precursor molecule, are cleaved by extra-cellular trypsin-like 
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proteases into HA1 and HA2 (4).  One of the factors that contributes to the increased 
pathogenicity of some influenza A viruses is the presence of a poly-basic amino acid 
cleavage site in the HA0 that can be cleaved by intracellular proteases or proteases found 
outside of the respiratory tract (20). 
 
 
Virus Ecology 
 
While their natural reservoir is aquatic birds, in which they cause an 
asymptomatic infection of the intestinal tract, influenza A viruses have the ability to 
infect a number of host species, most significantly swine, humans, poultry, and other 
terrestrial birds, but also horses, cats, dogs, and aquatic mammals such as seals and 
whales (151).  Influenza A viruses do exhibit host specificity, but this restriction is not 
absolute.  Several factors influence the host specificity of influenza viruses, including 
receptor binding.  Avian and equine influenza viruses have HA proteins that 
preferentially bind α-2,3 linked sialyloligosaccharides, which are widespread on the 
epithelium of the avian intestinal tract and equine trachea (52,53).  In contrast, human 
and swine influenza viruses contain HA proteins that preferentially bind α-2,6 linked 
sialyloligosaccharides, which are common on the epithelium of the mammalian 
respiratory tract (29,30).  Influenza A viruses in different species evolve along separate 
paths, but viruses of different lineages are able to exchange genetic information (151).   
 
The segmented nature of the influenza A virus genome enables these viruses to 
undergo reassortment if a single cell is concurrently infected with more than one virus 
(34).  These reassortment events can dramatically change the evolution of influenza A 
viruses in a host through the introduction of new gene segments (63).  Recent human 
pandemic influenza A viruses were created through the reassortment of human and avian 
viruses (127,121), causing an antigenic shift, which is the introduction of a novel HA into 
a naïve population.  In February 1957, a novel human-avian H2N2 reassortant virus 
emerged in the human population in southern China.  This virus contained the HA, NA, 
and PB1 from an avian influenza virus, while the remaining gene segments were from the 
circulating human H1N1.  The United States was affected in two waves, the first in 
October 1957 and the second in January 1958.  The first two waves of this virus caused 
about 70,000 deaths in the United States and about 1 million deaths worldwide (155).  In 
the summer of 1968, a reassortant H3N2 virus that had a novel HA and PB1 from an 
avian virus and the remaining gene segments from the previously circulating human 
H2N2 virus emerged in humans (151).  This virus caused about 34,000 deaths in the 
United States during the first two years it circulated (101).  The currently circulating 
H1N1 pandemic virus is the result of a reassortment between a human-avian-swine 
reassortant virus from the United States and an avian-like swine virus from Europe (33).  
From the time of its emergence in April 2009 through August 2009, it has been 
responsible for approximately 9,000 hospitalizations and almost 600 deaths in the United 
States (17)  
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Influenza A in Swine 
 
 
Swine as a Mixing Vessel.  Swine play an important role in the ecology of 
influenza A viruses because they are susceptible to viruses of both the avian and 
mammalian lineages.  The cells of the swine respiratory tract contain receptor 
sialyloligosaccharides possessing both N-acetylneuraminic acid-α2,3-galactose, which is 
the preferred receptor for avian influenza viruses and N-acetylneuraminic acid-α2,6-
galactose, which is the preferred receptor for mammalian influenza viruses (52,116).  
While only the H1 and H3 subtypes are endemic in swine, they are susceptible to 
infection with avian viruses of the H4-H13 subtypes (64).  This has led to the proposal 
that swine serve as a “mixing vessel” for influenza viruses of different lineages, 
providing a host in which reassortment and interspecies adaptation can take place (120).  
 
 
 Clinical Disease in Swine.  Influenza was first described as a disease of swine in 
1918 (66) and the first influenza A virus was isolated from a pig in 1930 (125).  Influenza 
A in swine has an incubation period of 12–48 hours and causes an acute respiratory tract 
infection characterized by high fever, loss of appetite, labored breathing, coughing, 
sneezing, nasal discharge, lethargy, and weight loss (105).  The virus replicates in the 
bronchial, bronchiolar, and alveolar epithelium, but is rarely found in the serum or other 
tissues (138,54).  Swine influenza is usually introduced into a herd through the movement 
of infected pigs, generally resulting in herd morbidity close to 100%, but very low 
mortality of less than 1% (143,105).  The virus is transmitted between pigs through 
nasopharyngeal secretions.  Once introduced into a herd, influenza will continue to 
circulate until there are no susceptible pigs remaining.  A vaccine which protects against 
the H1N1 and H3N2 swine influenza subtypes is commercially available for pigs over 
three weeks of age and is most commonly used to vaccinate sows in order to provide 
maternal antibodies to newborn piglets (105). 
 
 
Evolution of Swine Influenza Viruses in North America.  Reassortment has 
played a pivotal role in the evolution of influenza A viruses in North American swine.  
The first influenza A virus isolated from swine in 1930 was of the H1N1 subtype and was 
from the same lineage as the 1918 pandemic virus.  These viruses entered the human and 
swine populations at around the same time but evolved independently in each host 
(125,127).  This “classical” swine H1N1 virus continued to circulate as the dominant 
influenza virus in the North American swine population until 1998.  It caused predictable 
seasonal peaks of disease, similar to those seen in humans, and was not of great economic 
concern (36).  While classical H1N1 was the dominant virus, human H3N2 viruses were 
detected by serology at very low levels, but these viruses never became established in the 
swine population (18,50,106). 
 
In late 1998, two distinct H3N2 influenza viruses were isolated from swine with 
unusually severe influenza-like illness in North Carolina, Minnesota, Iowa, and Texas.  
The isolate from North Carolina was classified as a double reassortant virus and 
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contained HA, NA and PB1 genes similar to those of contemporary human H3N2 
influenza viruses and M, NP, NS, PA, and PB2 genes similar to those of the classical 
H1N1 swine influenza lineage.  This virus caused spontaneous abortion in 7% of 
breeding sows in the herd it was first isolated from and had about a 2% mortality rate 
(160), compared to a less than 1% mortality rate normally seen with swine influenza 
infection (105).  The isolates from Minnesota, Iowa, and Texas were classified as triple 
reassortant viruses and had even more complex genomes.  Like the North Carolina 
isolate, these viruses contained HA, NA, and PB1 genes from a contemporary human 
virus lineage and M, NP, and NS genes from the classical swine H1N1 lineage.  
However, these isolates contained PA and PB2 genes from an avian influenza virus 
lineage.  Disease caused by these triple reassortant viruses was less severe than that 
caused by the double reassortant virus, with lower morbidity and mortality rates, but the 
virus was able to spread throughout more swine herds in a larger geographical area 
(160,159).  After the emergence of these two reassortant viruses, the double reassortant 
virus did not continue to circulate, but the triple reassortant lineage became established in 
the swine population and continued to circulate and evolve.  By early 2000, over 20% of 
sampled pigs were seropositive for the triple reassortant H3N2 (149).  Further studies 
identified triple reassortant viruses in samples collected from pigs as early as March 1998 
(60). 
 
Variants of the original H3N2 triple reassortant virus continue to be isolated from 
the North American swine population along with several other lineages of influenza A 
viruses (Table 1-1).  Not all of the isolated viruses successfully become established in the 
swine population, but all of the currently circulating viruses contain a genetically similar 
constellation of internal genes with different surface glycoproteins.  This constellation of 
internal genes is referred to as the triple reassortant internal gene (TRIG) cassette, and is 
comprised of the avian-origin PB2 and PA gene segments, the human-origin PB1 gene 
segment, and the classical swine-origin NP, M, and NS gene segments (143).  This TRIG 
cassette is thought to provide a competitive advantage in swine compared to other 
internal gene constellations.  Influenza A viruses isolated from swine since 1998 include 
3 distinct H3N2 viruses, each with a human-like HA from a different year (149), an 
H1N2 virus with a human-like HA (57), an H1N2 virus with a classical swine-like HA 
(58), an H1N1 virus with a human-like HA and NA (142), and an H1N1 virus with a 
classical swine-like HA and NA (148).  Other reassortant virus subtypes that have 
sporadically been isolated from pigs since 1998, but have not become established in the 
swine population include an H3N1 and an H2N3 (83,84).  Several wholly-avian viruses, 
including an H4N6, H3N3, and H1N1 have been isolated from swine herds in Canada, 
but none have spread beyond the initially infected herds (56,104,61). 
 
 
Swine Influenza Evolution in Europe and Asia.  The evolution of swine 
influenza A viruses in Europe and Asia has been distinct from their evolution in North 
America.  Swine influenza was not reported in Europe until 1976, when the classical 
swine H1N1 virus was detected in pigs in Italy (100).  Around the same time, a wholly-
human H3N2 virus was also introduced into the European swine population (15), and in 
1979, a wholly avian-like influenza A virus was isolated from swine in Italy (108).  This  
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Table 1-1.  Influenza A Viruses Isolated from North American Swine since 1998. 
 
Subtype Origin 
Year 
Initially 
Isolated 
Country 
Isolated Reference 
H3N2 Swine/Human 1998 U.S. (160) 
H3N2 Swine/Human/Avian 1998 U.S. (160) 
H1N2 Reassortant Swine/Swine 1999 U.S. (58) 
H4N6 Avian 1999 Canada (59) 
H1N1 Reassortant Swine/Swine 2001 U.S. (148) 
H3N3 Avian 2001 Canada (61) 
H1N1 Avian 2002 Canada (61) 
H1N2 Human 2003 Canada (57) 
H3N1 Reassortant Swine/Reassortant Swine 2004 U.S. (83) 
H1N2 Reassortant Swine/Human 2004 Canada (57) 
H1N1 Reassortant Swine/Human 2005 U.S. (142) 
H2N3 Reassortant Swine/Avian 2006 U.S. (84) 
H1N1 Reassortant Swine/Avian 2009 Canada (153) 
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avian-like H1N1 virus quickly replaced the classical swine H1N1 virus as the dominant 
lineage and reassorted with the human H3N2 virus, resulting in a virus with human-like 
HA and NA genes and avian-like internal genes (16).  An H1N2 virus that contained a 
human-like H1, swine-like N2, and avian-like internal genes was isolated from swine in 
Great Britain in 1994 (11), and in 2005 a novel H1N2 virus that was the result of 
reassortment between a swine H1N2 virus and a swine H3N2 virus was isolated in 
Germany (158). 
 
Most of the European swine influenza viruses also circulate in Asia, but there are 
several lineages which are unique to this region.  Human H3N2 viruses were first isolated 
from pigs in Taiwan in 1970 (70) and continue to circulate in the swine population along 
with several different reassortant H3N2 viruses (107,156,126).  Interestingly, viruses with 
an HA and NA most closely related to the original human pandemic H3N2 isolate from 
1968 can still be isolated from pigs in China, along with more recent human H3N2 and 
human H1N1 viruses (157).  In China and Korea, several isolates have been detected that 
contain gene segments that are genetically similar to those found in the North American 
swine population (74).  In 2004, an H1N2 virus was isolated in Hong Kong that 
contained five of the internal genes from the North American triple reassortant swine 
viruses with a Eurasian lineage H1 and M (128).  In Thailand, several reassortant viruses 
have been isolated from swine, including an H1N1 that contains the HA and NS from the 
classical swine H1N1 lineage and the remaining genes from the Eurasian avian-like 
swine lineage.  An H1N2 reassortant virus with the HA from the classical swine H1N1 
lineage and the remaining genes from the Eurasian avian-like swine lineage was also 
isolated (25,132).  These two reassortant viruses have also been isolated from humans 
(67).  An avian H9N2 virus was isolated from pigs in Hong Kong in 1998 (107) but did 
not become established in the pig population of Asia.  A distinct H9N2 virus reassorted 
with and obtained the internal genes of an H5N1 virus and both the reassortant and the 
original H9N2 virus still circulate in pigs (28,156).  Avian H5N1 viruses have been 
isolated sporadically from swine in China and Indonesia, but do not appear to be highly 
pathogenic in swine, do not efficiently transmit from pig to pig, and have not become 
established in the population (24,161,131). 
 
 
Influenza Zoonoses 
 
The most catastrophic zoonotic influenza event was the H1N1 pandemic of 1918-
1919.  While it has long been proposed that this virus was a wholly avian virus that 
transmitted directly into the human and swine populations (114), new evidence suggests 
that the virus was actually the result of several reassortment events between human, 
swine, and avian influenza viruses (127).  In early 1918, there was a mild wave of 
disease, which was followed in the fall by a highly pathogenic wave that killed more than 
20 million people worldwide (133,134,5).  Related H1N1 viruses remained in the human 
and swine populations, evolving along separate paths (127). H1N1 viruses were replaced 
in the human population by viruses of the H2N2 subtype in 1957 but were re-introduced 
into the human population in 1977 (151). 
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The first swine influenza virus was isolated from a human in 1974.  Forty-three 
confirmed cases of transmission of influenza A virus from pigs to humans were reported 
between 1974 and 2005, including six fatalities.  Because there are no unique clinical 
symptoms to differentiate swine influenza from seasonal influenza in humans, this 
number is probably only a small fraction of the actual cases (124).  Serological studies on 
swine farm workers, meat-packers, and veterinarians showed a high frequency of 
exposure to several subtypes of swine influenza viruses (46,98)  Most of the reported 
cases of swine flu infections in humans were the result of direct exposure to swine or 
were human-to-human transmission within a family cluster (97).  An exception was in 
early 1976, when there was an outbreak of severe respiratory disease at Fort Dix, New 
Jersey.  Thirteen soldiers became severely ill, and one died.  The causative agent of the 
outbreak was determined to be a classical swine H1N1 virus.  Further serological studies 
showed that over 200 infections occurred, however, within a month, the virus had 
disappeared from the human population (44).  From December 2005 through February 
2009, 11 cases of human infection with swine influenza were reported to the CDC.  
These infections were all caused by triple reassortant swine influenza viruses.  Ten of the 
infections were caused by an H1N1 virus with classical swine origin HA and NA genes, 
and one was caused by an H1N2 virus with human origin HA and NA genes.  Four of the 
patients were hospitalized, but no deaths were reported (124). 
 
In April 2009, two cases of un-subtypeable influenza A in humans with no known 
swine contact were reported in southern California.  The viruses isolated from these cases 
were of swine origin, but were distinct from the influenza A viruses currently known to 
be circulating in the North American swine population.  They appeared to be the result of 
reassortment between a North American triple reassortant lineage swine virus and a 
Eurasian H1N1 swine virus.  The HA gene and the internal genes were similar to those 
found in circulating reassortant swine viruses, but the NA and M genes were more 
closely related to the Eurasian avian-like swine influenza A lineage (33).  The origin of 
this virus is currently unknown, but it has spread in humans throughout the United States 
and around the world and was declared a pandemic virus on 11 June 2009 (19).  The 
virus has also been detected in swine herds in Canada (153,38), Australia (14), Ireland 
(115,45), Argentina (1), and the U.S. (26) but it remains to be seen if it will become 
established in the swine population worldwide and if it will replace the currently 
circulating strains. 
 
 
Research Aims and Hypotheses  
 
Swine influenza is a dynamic zoonotic disease.  The continued rapid and as yet 
unpredictable evolution of swine influenza A viruses poses a threat to human health, as 
evidenced by the recent emergence of a novel H1N1 pandemic influenza virus of swine 
origin.  Despite yearly human epidemics, four pandemics in the last century, and the 
veterinary impact of influenza A viruses, we know little about the fundamental biologic 
properties of these viruses.  The purpose of this study was to characterize the pandemic 
potential of reassortant influenza A viruses of swine, assess their fitness as compared to 
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other swine influenza viruses, as well as to examine the reassortment potential of these 
viruses. 
 
 
Hypothesis 1.  North American swine influenza viruses containing the TRIG 
cassette are able to acquire surface glycoproteins from an avian influenza virus through 
reassortment, and the adaptation of these viruses in pigs can lead to a virus that is 
transmissible in mammals through minor changes in the HA which alter receptor 
specificity. 
 
 
Hypothesis 2.  The avian-origin polymerase genes of reassortant swine influenza 
A viruses give these viruses a replicative advantage over classical swine influenza viruses 
both in vitro and in vivo and confer the ability to acquire human HA gene segments. 
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CHAPTER 2: TRANSMISSIBILITY OF A NOVEL H2N3 SWINE INFLUENZA 
VIRUS 
 
 
Introduction 
 
Influenza A viruses are classified into subtypes based on the antigenic properties 
of their two surface glycoproteins, HA and NA.  HA is the receptor binding protein of the 
virus and as well as its main antigenic determinant.  It binds with terminal sialic acid 
residues on the surface of host cells and allows for viral entry into the cell.  There are 16 
HA and 9 NA subtypes that have been identified (39,151).  Viruses of all these subtypes 
can be isolated from wild aquatic birds, the natural reservoir of influenza A viruses, 
however, only three subtypes have caused human pandemics – H1, H2, and H3 (151). 
 
The host specificity of influenza A viruses is largely due to the receptor binding 
specificity of the HA.  The HA of avian-origin influenza A viruses binds preferentially to 
α-2,3 linked sialyloligosaccharides on the surface of avian intestinal epithelial cells (52), 
while the HA of mammalian-origin influenza A viruses binds preferentially to α-2,6 
linked sialyloligosaccharides on epithelial cells in the respiratory tract (116).  A single 
amino acid substitution at position 226 (H3 numbering) of the HA1 protein has been 
shown to be responsible for the receptor preference in H2 and H3 subtypes.  An HA with 
a glutamine (Q) at position 226 will preferentially bind α-2,3 linked 
sialyloligosaccharides, while an HA with leucine (L) at position 226 will preferentially 
bind α-2,6 linked sialyloligosaccharides.  An additional substitution from glycine to 
serine at position 228 has also been observed as H2 viruses adapt from avian hosts to 
mammalian hosts (29), but the effect of this mutation on receptor specificity and viral 
transmission is unknown. 
 
Swine have been proposed as an intermediate host between birds and mammals 
for influenza A viruses because the cells of the swine respiratory tract contain both α-2,3 
and α-2,6 linked sialyloligosaccharide receptors (120,52).  This makes swine susceptible 
to both avian and human influenza A viruses.  Replication of an avian influenza virus in a 
pig can lead to its adaptation to a mammalian host through mutation or reassortment with 
a co-infecting influenza A virus (120).  Pigs are also able to transmit influenza A viruses 
to humans (97).  The Fort Dix outbreak of  1976 was caused by a classical swine H1N1 
virus and there have been eleven reported cases of triple reassortant swine influenza 
infection in humans since 2005 (44,97).  
 
Influenza A viruses of the H2N2 subtype were first detected in the human 
population in 1957, causing the second pandemic of the 20th century.  The pandemic 
virus was the result of reassortment between the H1N1 virus that had circulated in the 
human population since the 1918 pandemic and an avian H2N2 virus.  This reassortment 
produced a virus with avian-origin HA, NA, and PB1 genes and human-origin PB2, PA, 
NP, M, and NS genes (121).  H2N2 influenza viruses circulated in the human population 
until 1968, when an H3N2 virus emerged and replaced the H2N2 subtype.  H2 influenza 
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viruses continued to circulate in birds, but were not isolated from humans or other 
mammals, including pigs, after 1968 (151). 
 
In 2006, two H2N3 viruses were isolated from separate swine herds in Missouri.  
Analysis of these viruses showed that they contained HA, NA, and PA genes from avian 
influenza viruses and the remaining genes from the North American triple reassortant 
swine influenza lineage.  These viruses were the first swine viruses isolated in North 
America which contained the TRIG cassette along with avian surface glycoproteins, 
demonstrating the ability of this gene constellation to acquire a wide range of novel HA 
genes and bring them into a naïve population.  Sequencing of the two isolates showed 
that both isolates contained a leucine (mammalian-like) at position 226 and a glycine 
(avian-like) at position 228 of the HA1.  This novel H2N3 virus was found to be 
pathogenic and transmissible in pigs and also pathogenic in mice without adaptation (84). 
 
Because H2N3 viruses have not been isolated from humans since 1968, and pigs 
can transmit influenza A viruses to humans, a mammalian-adapted H2N3 virus in the 
swine population would have a high pandemic potential.  The mechanisms controlling 
interspecies transmission of influenza A viruses are not well defined.  Receptor 
specificity has been shown to play a role in the ability of a virus to infect a host, though it 
has not previously been linked to transmissibility in H2 subtype viruses.  Transmission 
studies in ferrets showed that receptor specificity was responsible for direct contact 
transmission of the virus, and that this transmissibility was attenuated by changing the 
leucine at position 226 of the HA1 back to the avian consensus glutamine.  While there 
are several animal models that can be used to characterize influenza A viruses, ferrets are 
highly suitable for infection and transmission studies of influenza A viruses because they 
are naturally susceptible to the virus, exhibit symptoms of disease similar to those seen in 
humans (129), and have receptor distribution in the airway that is similar to humans 
(75,85). 
 
 
Materials and Methods 
 
 
 Viruses Used.  Three wild-type viruses were used to characterize the transmission 
of H2N3 viruses in ferrets.  SW/MO/2124514/06 (SW/MO/06) is one of the original 
swine H2N3 isolates.  A/Mallard/Alberta/79/03 (Mal/Alb/03) is an H2N3 virus that 
contains an HA with 98.8% amino acid homology to the HA of SW/MO/06.  
CK/OH/494832/07 (CK/OH/07) is an H2N3 virus that contains an HA and NA similar to 
those of SW/MO/06 (97.7% and 98.5% amino acid homology respectively).  SW/MO/06 
and CK/OH/07 were obtained from Dr. Marie Gramer at the University of Minnesota 
Veterinary Diagnostic Laboratory, and Mal/Alb/03 was obtained from the virus 
repository at St. Jude Children’s Research Hospital.  All virus stocks were grown in 
embryonated hen eggs and stored at -80°C. 
 
 
 
 
13 
 Generation of Reverse Genetics Viruses.  Three additional H2N3 viruses were 
generated using the eight plasmid reverse genetics system (Figure 2-1).  cDNA for each 
gene segment was synthesized and ligated into the plasmid pHw2000.  The insertion site 
is flanked by a human RNA polymerase I promoter sequence and a murine terminator 
sequence.  The entire polymerase I and cDNA sequence is flanked by an RNA 
polymerase II promoter sequence and a poly-adenylation site.  Upon transfection into a 
co-culture of 293T and Madin-Darby Canine Kidney (MDCK) cells, both vRNA and 
mRNA are synthesized from each plasmid (51).  To obtain an H2 virus with altered 
receptor specificity, a t707a (L226Q) mutation was introduced into the SW/MO/06 HA 
plasmid through site-directed mutagenesis, the plasmid was sequenced to confirm the 
mutation, and the virus was rescued as described.  For each of the three viruses rescued, 
1ug of each plasmid was transfected into MDCK/293T cell co-culture and incubated for 
72 hours.  Supernatants were harvested and injected into eggs.  Eggs were incubated for 
48 hours and the allantoic fluid was collected.  The genetic constellation of all viruses 
was confirmed by sequencing. 
 
The viruses rescued were rgSW/MO/06, which contained the HA, NA, and PA 
genes from SW/MO/06 and the remaining five genes from SW/TX/4199-2/98 (Table 2-
1); rgSW/MO/06 HAmut, which contained the HA gene from SW/MO/06 containing a 
t707a mutation, NA and PA genes from SW/MO/06, and the remaining five genes from 
SW/TX/98; and rgCK/OH/07, which contained the HA gene from CK/OH/07, the NA 
and PA genes from SW/MO/06, and the remaining five genes from SW/TX/98.  
rgSW/MO/06 and rgCK/OH/07 were rescued to compare their properties to wild-type 
virus.  rgSW/MO/06 HAmut was rescued to determine if the L226Q mutation would alter 
the virus’s growth and transmissibility. 
 
 
 Ferret Infections.  Influenza A negative ferrets were obtained from the ferret 
breeding program at St. Jude Children’s Research Hospital or from Triple F Farms 
(Sayre, PA).  Infectivity and transmissibility of each influenza H2 virus was tested in six 
3-4 month old ferrets per virus under BSL-2 conditions.  Three ferrets were anesthetized 
with isofluorane and inoculated intranasally with 105 TCID50 (Mal/Alb/03 and 
SW/MO/06) or 106 TCID50 (CK/OH/07, rgSW/MO/06, rgSW/MO/06HAmut, 
rgCK/OH/07) of virus diluted in PBS.  Twenty-four hours post-inoculation, one naïve 
contact animal was housed with each infected animal.  At days 1, 4, 7 and 11 post-
inoculation, animals were anesthetized with ketamine and nasal washes were collected. 
The nasal washes were titrated in embryonated hen eggs and egg 50% infectious dose 
(EID50) was calculated using the Reed-Muench method (113). 
 
 
Hemagglutination Inhibition (HI) Assays.  Serum samples were collected at 21 
days post-infection and treated overnight at 37°C with Vibrio cholerae receptor-
destroying enzyme (Denka-Sekien, Tokyo, Japan) followed by heat inactivation at 56°C 
for 30 minutes prior to serological testing.  Sera were titrated in round bottom 96-well 
plates and incubated for 45 minutes at room temperature with four agglutinating doses of  
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Figure 2-1.  Eight Plasmid Reverse Genetics System.  A PCR synthesized cDNA 
molecule was created for each gene segment and ligated into the pHw2000 plasmid.  The 
eight plasmids were then transfected into a co-culture of 293T and MDCK cells and 
incubated at 37°C for 72 hours.  Modified with permission.  Hoffmann E, Neumann G, 
Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of 
influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 2000 May 
23;97(11):6108-13. 
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Table 2-1.  H2N3 Viruses Rescued Using Reverse Genetics. 
 
Virus Gene Segment Virus of Origin PB2 PB1 PA HA NP NA M NS 
rgSW/MO/06 SW/TX/98 SW/TX/98 SW/MO/06 SW/MO/06 SW/TX/98 SW/MO/06 SW/TX/98 SW/TX/98 
rgSW/MO/06 
HAmut 
SW/TX/98 SW/TX/98 SW/MO/06 SW/MO/06 
L226Q 
SW/TX/98 SW/MO/06 SW/TX/98 SW/TX/98 
rgCK/OH/06 SW/TX/98 SW/TX/98 SW/MO/06 CK/OH/07 SW/TX/98 SW/MO/06 SW/TX/98 SW/TX/98 
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homologous virus.  A 0.5% solution of turkey red blood cells was then added and 
incubated at room temperature for 30 minutes.  HI titer was determined based on the 
highest dilution of sera which caused complete inhibition of red blood cell agglutination. 
 
 
Results 
 
 
Swine H2N3 Viruses Are Transmissible in Ferrets.  To determine if 
SW/MO/06 was transmissible in the ferret model, three ferrets were inoculated 
intranasally with 105 TCID50 of SW/MO/06 or 106 TCID50 of rgSW/MO/06.  One naïve 
contact animal was housed with each inoculated animal beginning 24 hours post-
inoculation.  Ferrets inoculated with both wild-type and rgSW/MO/06 shed detectable 
amounts of virus by day one post-inoculation with average titers of 105.5 EID50/ml for 
wild-type and 106.25 EID50/ml for the reverse genetics virus (Figure 2-2).  Contact ferrets 
in both groups began to shed virus by day three post contact with average titers of 106.17 
EID50/ml for wild-type and 105.17 EID50/ml for the reverse genetics virus.  All ferrets 
cleared the virus within seven days of infection, and none of the ferrets showed any 
clinical symptoms or lost a significant amount of weight (Table 2-2 and Table 2-3). 
 
 
 Avian H2N3 Viruses Replicate in Ferrets but Do Not Transmit Efficiently.  
To determine if avian H2N3 viruses were transmissible in ferrets, three ferrets were 
inoculated with 105 TCID50 of Mal/Alb/03, 106 TCID50 of CK/OH/07, or 106 TCID50 of 
rgCK/OH/07.  Twenty-four hours post-inoculation, one contact ferret was housed with 
each inoculated ferret.  Ferrets infected with Mal/Alb/03 shed detectable levels of virus 
by one day post-inoculation, although the average titer of 104.4 EID50/ml was lower than 
that observed in ferrets infected with SW/MO/06.  Only one of the three contact ferrets 
shed detectable levels of virus at days 7 and 11 post-infection, 106.75 EID50/ml and 105.5 
EID50/ml, respectively (Figure 2-3A).  This contact ferret shed higher titers of virus than 
the infected ferrets, and when the HA of the isolated virus was sequenced, it was shown 
that the HA gene coded for a leucine at position 226 of the HA1 instead of the wild-type 
glutamine.  This Q226L mutation alters the receptor specificity of the HA from avian-like 
to mammalian-like.  The two contact ferrets that did not shed virus also did not have 
detectable HI titers (Table 2-3).  Following intranasal infection with wild-type or reverse 
genetics CK/OH/07, ferrets began to shed virus by day one post-infection to similar titers 
as Mal/Alb/03, with an average titer of 104.08 EID50/ml for wild-type and 103.58 EID50/ml 
for the reverse genetics virus (Figures 2-3B and 2-3C).  Wild-type CK/OH/07 was not 
detectable in the nasal washes of the contact ferrets although one contact animal did 
seroconvert.  rgCK/OH/07 was not detected in the nasal washes of any of the contact 
ferrets and none of the contact animals seroconverted.  No clinical symptoms were 
observed in any of the infected or contact ferrets (Table 2-2 and Table 2-3). 
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Figure 2-2.  Swine H2N3 Viruses Replicate and Transmit in Ferrets.  Three ferrets 
were inoculated intranasally with 105 TCID50 of SW/MO/06 (A) or 106 TCID50 of 
rgSW/MO/06 (B).  Twenty-four hours post-inoculation, one naïve contact ferret was 
placed in the cage with each inoculated ferret.  Nasal washes were collected 1, 4, 7, and 
11 days post-inoculation and viral titers were determined by EID50. 
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Table 2-2.  Weight Loss, Peak Viral Titers, and Serum HI Titers of Inoculated Ferrets. 
 
 Inoculated Ferrets 
Virus Weight Loss 
(%) 
Peak Titera 
(day) 
Serum HI Titerb 
SW/MO/06 4.67±1.24 5.75 (1) 160, 320, 320 
rgSW/MO/06 5.17±3.57 7.25 (1) 1280, 1280, >5120 
rgSW/MO/06 HAmut 7±3.56 6.5 (4) 80, 160, 320 
CK/OH/07 0.70±0.57 4.75 (1) 80, 80, 160 
rgCK/OH/07 0c 3.75 (1) 20, 80, 80 
Mal/Alb/03 8.33±2.87 4.75 (4) 80, 80, 160 
 
aTiters are shown as the log10 EID50/ml. 
bHomologous virus was used in HI assays. 
cNone of the ferrets lost weight. 
 
 
 
 
 
Table 2-3.  Weight Loss, Peak Viral Titers, and Serum HI Titers of Contact Ferrets. 
 
 Contact Ferrets 
Virus Weight Loss 
(%) 
Peak Titera 
(day) 
Serum HI Titerb 
SW/MO/06 3c 6.75 (6) 160, 320, 320 
rgSW/MO/06 3.87±3.67 5.5 (6) 640, 640, 2560 
rgSW/MO/06 HAmut 1.6c 6.5 (6) <10, <10, 160 
CK/OH/07 2.5c NTd <10, <10, 320 
rgCK/OH/07 1.5c NTd <10, <10, <10 
Mal/Alb/03 7.67±1.86 6.75 (6) <10, <10, 160 
 
aTiters are shown as the log10 EID50/ml. 
bHomologous virus was used in HI assays. 
cOnly one of the ferrets lost weight. 
dNo detectable titer. 
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Figure 2-3.  Avian H2N3 Viruses Replicate but Do Not Transmit Efficiently in 
Ferrets.  Three ferrets were inoculated intranasally with 105 TCID50 of Mal/Alb/03 (A), 
106 TCID50 of CK/OH/07 (B), or 106 TCID50 of rgCK/OH/07 (C).  Twenty-four hours 
post-inoculation, one naïve contact ferret was housed with each inoculated ferret.  Nasal 
washes were collected 1, 4, 7, and 11 days post-inoculation and viral titers were 
determined by EID50. 
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 A Single Amino Acid Change in the HA Abolishes the Ability of a Swine 
H2N3 Virus to Transmit in Ferrets.  Because the presence of a leucine at position 226 
of the HA1 has been shown to play a significant role in host receptor binding specificity, 
we used site-directed mutagenesis to change the position 226 leucine of SW/MO/06 HA 
to a glutamine and used reverse genetics to rescue a virus containing this mutation.  Three 
ferrets were infected with 106 TCID50 of rgSW/MO/06 HAmut and three contact animals 
were housed with the infected animals beginning 24 hours post-inoculation.  Following 
infection with rgSW/MO/06 HAmut, ferrets shed detectable levels of virus by day one 
post-infection and had titers similar to those of ferrets infected with rgSW/MO/06, with 
an average titer of 105.92 EID50/ml (Figure 2-4).  Virus was isolated from the nasal wash 
of one contact ferret at day three and day six post contact with titers of 102 EID50/ml and 
106.5 EID50/ml, respectively.  When virus isolated from the infected contact ferret on day 
six post-contact was sequenced, it was found that position 226 of the HA had reverted 
back to a leucine. 
 
 
Discussion 
 
 For an influenza pandemic to occur, several criteria must be met, including the 
introduction of a virus that contains an HA to which the host population has little or no 
pre-existing immunity (65).  The emergence in swine of an H2N3 virus that has the 
ability to transmit between mammals is of great concern because H2 influenza viruses 
have not circulated in the human population since 1968 (151).  Another criteria for an 
influenza pandemic virus is the ability to transmit between humans, a trait that is most 
often modeled in ferrets (85).  The swine H2N3 virus examined here transmitted very 
efficiently in the ferret direct contact model, and a single amino acid change in the HA 
abolished the virus’s transmissibility.  Two avian H2N3 viruses could also replicate in 
ferrets and one was capable of gaining transmissibility. 
 
 Although rgCK/OH/07 contains the same internal genes and NA gene as 
rgSW/MO/06 and rgSW/MO/06 HAmut, it replicated to lower titers, indicating that 
further changes in the HA may be necessary for optimal replication efficiency.  Other 
than the Q226L change in the receptor binding site, there is only one other amino acid 
difference between the HA proteins of CK/OH/07 and SW/MO/06 that is also observed 
in human H2 viruses.  CK/OH/07 has a phenylalanine residue at position 142, while 
SW/MO/06 and other human H2 isolates have a serine at this position.  This change has 
not been previously described and its impact on replication and transmissibility is 
unknown.  Because the NA from SW/MO/06 was used, it is also possible that an HA/NA 
mismatch was responsible for the lower replication seen, as balanced HA and NA activity 
has been shown to be important for efficient viral replication (95). 
 
 Examination of the amino acid sequences of the HAs of CK/OH/07, SW/MO/06, 
an early human H2N2 virus (A/Singapore/1/57), and a late human H2N2 virus 
(A/Berkley/1/68), showed nine amino acid residues where the swine sequence matched 
the avian sequence but differed from both early and late human viruses (Figure 2-5A).  
An additional 13 residues were conserved among the avian, swine, and early human HAs,  
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Figure 2-4.  A Receptor Binding Mutant Swine H2N3 Virus Replicates but Does Not 
Efficiently Transmit in Ferrets.  Three ferrets were inoculated intranasally with 106 
TCID50 of rgSW/MO/06 HAmut.  Twenty-four hours post-inoculation, one naïve contact 
ferret was housed with each infected ferret.  Nasal washes were collected 1, 4, 7, and 11 
days post-inoculation and viral titers were determined by EID50. 
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Figure 2-5.  Amino Acid Differences in the Amino Acid Sequences of Avian, Swine, 
and Human H2 Viruses.  (A) There are nine amino acid residues which are conserved 
between the avian and swine viruses but differ from early and late human H2 viruses.  
(B) There are 13 amino acid residues which are conserved between the avian, swine, and 
early human H2 viruses but differ from the late human H2 virus. 
4 114 214 228 242 314 375 401 460 
CK/OH/07 K T I G V R I N A 
SW/MO/06 K T I G V R I N A 
A/Singapore/1/57 R K T S T K F S V 
A/Berkley/1/68 R K T S T K F S V 
HA Amino Acid Position 
93 131 144 159 193 197 204 205 219 244 252 499 507 
CK/OH/07 G T N S T N V G T N I N K 
SW/MO/06 G T N S T N V G T N I N K 
A/Singapore/1/57 G T N S T N V G T N I N K 
A/Berkley/1/68 S E K P A E E A A S V K E 
HA Amino Acid Position 
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but differed from the late human virus sequence (Figure 2-5B).  These residues are likely 
involved in the adaptation of the virus for optimal replication and transmission in 
humans. 
 
Position 226 of the HA1 has been shown to be associated with receptor binding 
specificity in several subtypes of influenza A viruses, including H5 and H9 (47).  It has 
been shown that the Q226L mutation in avian H9N2 viruses allowed for direct contact 
transmission among ferrets, but not aerosol transmission.  In contrast to our results 
however, introducing an L226Q mutation into the HA of an H9 virus decreased 
replication efficiency of the virus in ferrets, along with abolishing direct transmission 
(145), while the H2N3 virus containing the L226Q mutation showed no replication 
defect.  Although the amino acids responsible for receptor binding in H1 viruses differ 
from those in H2 viruses, it has been shown that a two amino acid change in the HA of a 
1918 H1N1 virus which changes the receptor specificity from α-2,6 to α-2-3 linkages 
abolishes aerosol transmission, and a virus with a single amino acid change that results in 
dual receptor binding transmits inefficiently (136).  However, receptor binding had not 
previously been associated with transmissibility in the H2 subtype.  The Q226L mutation 
was noted early in the 1957 H2N2 pandemic, along with a later G228S mutation.  This 
G228S mutation has not been observed in swine H2N3 viruses and its contribution to the 
receptor binding specificity of the virus is unclear (84).  Because both the H2 and H9 
viruses tested retained the avian residue at position 228 and were able to transmit only by 
direct contact, it is possible that this amino acid may have a role in the aerosol 
transmission of the virus.  When ferrets were infected with viruses containing glutamine 
at HA position 226, two of the three viruses quickly mutated to leucine at this position 
and were able to transmit to contacts.  The ease with which these viruses can adapt to a 
mammalian host greatly increases their pandemic potential. 
 
 Because rgCK/OH/07, which contains the avian HA on the TRIG backbone, does 
not replicate more efficiently in ferrets than the wild-type wholly-avian CK/OH/07, it 
does not appear that the presence of the TRIG cassette provides a replicative advantage 
for these viruses in the ferret model.  It also does not appear that the TRIG cassette is 
necessary for the adaptation of the HA, as wild-type Mal/Alb/03 was able to gain 
transmissibility through the Q226L mutation.  However, in pigs, the reassortant virus was 
isolated, while wholly-avian viruses were not, indicating that the TRIG may confer an 
advantage in pigs.  The main contribution of the TRIG cassette appears to be acquiring 
new HA and NA genes and bringing them into the swine population.  While direct 
transmission of influenza viruses from birds to humans does occur, it is not a common 
event and is usually only seen with highly pathogenic avian influenza viruses (55).  
However, the transmission of influenza viruses from pigs to humans is much more 
frequent (97).  Although at this time H2N3 viruses do not appear to have become 
established in the swine population, the isolation of this virus along with the emergence 
of the novel pandemic H1N1 influenza A virus, which also contains elements of the 
TRIG cassette (33), highlights the importance of swine in the evolution of influenza A 
viruses and their introduction into the human population. 
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CHAPTER 3: IN VITRO REASSORTMENT OF SWINE INFLUENZA A 
VIRUSES 
 
 
Introduction 
 
The segmented nature of the influenza A virus genome allows these viruses to 
rapidly evolve through the process of reassortment (34).  Reassortment occurs when a 
single host cell is concurrently infected with two different influenza A viruses.  As the 
genomes of these viruses are replicated and packaged, gene segments from the two 
separate viruses can be packaged into a single virion, creating a genetically novel virus 
(151).  Successful reassortment depends on several factors. 
 
1) A single cell must be infected with at least two different viruses. 
2) The genomes of both viruses must be packaged together in progeny 
virions. 
3) The resulting reassortant viruses must be as least as fit as the parental 
viruses. 
 
 Reassortment of influenza A viruses has played a role in the generation of the last 
four influenza pandemics in humans through antigenic shift (33,127,121).  Antigenic shift 
occurs when the result of a reassortment event is a virus with an HA that is novel to the 
host population.  In 1957, an avian virus and a human virus reassorted to create an H2N2 
virus that contained the HA, NA, and PB1 genes from an avian virus and the remaining 
gene segments from the previously circulating human virus.  This new H2N2 virus 
replaced the circulating H1N1 virus and remained in the human population until the next 
pandemic virus emerged in 1968.  In 1968, the H2N2 virus underwent another 
reassortment event with an avian virus and acquired an avian H3 and a novel avian PB1 
(151).  Descendents of this virus still circulate in the human population.  In 2009, an 
influenza A virus that was the product of a reassortment between a North American triple 
reassortant swine virus and a Eurasian H1N1 swine virus caused the first influenza 
pandemic of the 21st century(33,154).  Swine have long been proposed as a mixing vessel 
for influenza A viruses from different host species due to the presence of both avian-like 
and mammalian-like sialic acid receptors in their respiratory tracts and, in many 
countries, their close proximity to both birds and humans (52,120). 
  
Prior to 1998, swine influenza in North America was caused by a stable lineage of 
H1N1 viruses related to the pandemic strain of 1918 (18,50,106).  However, in 1998, two 
groups of novel H3N2 viruses were isolated from swine in the U.S.  These viruses were 
genetically and antigenically distinct both from each other and from previously isolated 
swine influenza viruses and both were reassortants (160).  While the double reassortant 
virus, containing gene segments of human and classical swine origin, did not become 
established in the swine population, the triple reassortant lineage, which contained gene 
segments of human, classical swine, and avian origin, quickly became established and 
spread throughout North America (149). 
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As the triple reassortant viruses spread through the pig population, they continued 
to reassort with other circulating viruses, maintaining their internal gene constellation, 
which has been designated the triple reassortant internal gene (TRIG) cassette, but 
acquiring novel HA and NA genes from both human and swine viruses.  Between 1998 
and 2008, three distinct H3N2 viruses, two distinct H1N1 viruses, and two distinct H1N2 
viruses were isolated from North American swine (148,143).  The TRIG cassette has also 
shown the ability to acquire avian-origin HA and NA genes and introduce them into the 
swine population, as occurred with the H2N3 viruses isolated from pigs in 2006 (84).  
This frequent introduction of HA and NA genes of different subtypes into the swine 
population is in marked contrast to the situation prior to the introduction of the TRIG 
cassette, when H3 viruses were rarely detected in pigs (18,50,106). 
 
Although reassortment plays an important role in the evolution of influenza A 
viruses, little is known about the mechanisms controlling the frequency of successful 
reassortment events and the impact of viral replication, genome packaging, and genome 
compatibility.  Several different subtypes of swine influenza viruses containing the TRIG 
cassette have been isolated since 1998.  In contrast, the classical swine lineage remained 
unchanged for close to 80 years.  This epidemiological data suggest that there is some 
intrinsic property of the TRIG cassette that allows it to easily acquire different HA genes.  
Three internal genes differ between triple reassortant swine viruses and classical swine 
viruses, PA, PB1, and PB2.  Therefore these genes are the most likely to be responsible 
for the observed increase in reassortment frequency.  To characterize the reassortment of 
swine influenza viruses in vitro, and determine if a swine virus containing the TRIG 
cassette was better able to acquire a human HA than a classical swine virus, a PCR assay 
was developed to determine the frequency with which a classical or reassortant swine 
H1N1 influenza virus was able to acquire a human H3 gene. 
 
 
Materials and Methods 
 
 
Viruses Used.  Three influenza A viruses were used in the analysis of the 
reassortment of swine influenza A viruses.  A/TX/6/96 (TX/96) is a human H3N2 virus 
which has HA and NA genes similar to those found in early swine H3N2 reassortant 
viruses.  SW/MN/37866/99 (SW/MN/99) is an H1N1 virus of the classical swine lineage 
(Figure 3-1A), and SW/NC/18161/02 (SW/NC/02) is a triple reassortant H1N1 virus with 
5 genes (HA, NA, M, NP, and NS) from the classical swine lineage, 1 gene (PB1) from 
the human H3N2 lineage, and two genes (PA and PB2) from an avian lineage (Figure 3-
1B).  TX/96 was obtained from the Centers for Disease Control and Prevention, 
SW/MN/99 was obtained from Dr. Marie Gramer at the University of Minnesota 
Veterinary Diagnostic Laboratory, and SW/NC/02 was obtained from Dr. Gene Erickson 
at the Rollins Animal Disease Laboratory.  Stocks of all viruses were grown in MDCK 
cells for 72 hours at 35°C and stored until use at -80°C.  Viral titers were determined by 
TCID50. 
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Figure 3-1.  Swine Viruses Used for Reassortment Studies.  Gene segments from the 
classical swine lineage are in green.  Gene segments from the human H3N2 lineage are in 
blue.  Gene segments from the avian lineage are in yellow. (A) SW/MN/99 is a classical 
swine H1N1 virus.  (B) SW/NC/02 is a triple reassortant swine H1N1 virus. 
PB2 PB2 
PB1 PB1 
PA PA 
HA HA 
NP NP 
NA NA 
M M 
NS NS 
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Co-infection of MDCK Cells.  Twenty-four well tissue culture plates were 
seeded with MDCK cells and the cells were allowed to reach 90% confluency.  Dilutions 
of the stock viruses were made in MDCK infection media (1X MEM supplemented with 
antibiotic/antimycotic solution, vitamin solution, and bovine serum albumin).  To 
determine if optimal conditions existed for the reassortment of swine and human 
influenza viruses, virus dilutions of 5, 1, 0.1, and 0.01 multiplicities of infection (MOI) 
were made for each virus (TX/96, SW/MN/99, and SW/NC/02).  Cells were infected 
simultaneously with TX/96 and either SW/MN/99 or SW/NC/02 or cells were singly 
infected with SW/MN/99 or SW/NC/02 and then infected with TX/96 following a 24  
hour incubation (Figure 3-2).  Because polymerase genes influence the ability of viruses 
to replicate at different temperatures (8), cells were incubated at either 37°C or 39°C for 
48 hours post-infection.  Cell supernatants were harvested and stored at 4°C until 
selection for H3 viruses and then were stored at -80°C. 
 
 
H1 Neutralization.  In order to select for viruses which contained the human H3, 
after cell supernatants were harvested, 30ul of the supernatant was combined with 30ul of 
swine serum raised against SW/MN/99 or SW/NC/02 and incubated at 4°C for 1 hour.  
240ul MDCK infection media was added and 250ul of this mixture was added to MDCK 
cells in a 24 well plate.  Cells were incubated for 48 hours at either 37°C or 39°C and 
supernatants were collected.  Supernatants were stored at 4°C until RNA extraction and 
then were stored at -80°C. 
 
 
RNA Extraction.  RNA was extracted from cell supernatants using the MagMax 
AI/ND RNA extraction kit from Ambion on a KingFisher machine.  Control RNA was 
extracted from stored supernatants of TX/96, SW/MN/99, and SW/NC/02 using the 
RNeasy Mini-Kit from Qiagen.  Control RNA was diluted to 5ng/ul.  RNA was stored at 
4°C and analyzed within four days of extraction. 
 
 
Primer Design.  Primers were designed based on the sequences of the PA and 
PB2 genes of SW/MN/99 and SW/NC/02 in order to determine if these gene segments 
were present in the isolated H3 viruses.  Primers chosen for testing had at least five 
nucleotide differences between the swine virus and TX/96, and amplified a 200-500 base 
pair segment.  H3 specific primers were designed based on the sequence of TX/96.  
Previously designed H1 and M specific primers were used for the amplification of these 
segments (Table 3-1). 
 
 
Primer Optimization.  One-step reverse-transcriptase PCR (RT-PCR) (Qiagen) 
was performed under a variety of conditions to determine conditions under which each 
primer set was discriminatory. All reactions had a constant reverse transcriptase step of 
30 minutes at 55°C and a Taq activation step of 15 minutes at 95°C.  Reactions were run 
with 35 or 40 cycles and annealing temperatures ranging from 50°C to 59°C, using 10ng 
TX/96, SW/MN/99, or SW/NC/02 as templates.  All PCR products were visualized on a  
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Figure 3-2.  Combinations of Human and Swine Virus Inoculums Used to Infect 
MDCK Cells.  TX/96 was added to cells simultaneously or 24 hours after infection with 
SW/MN/99 (A) or SW/NC/02 (B). 
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Table 3-1.  Primer Sequences and PCR Conditions Used to Detect Reassortant Viruses. 
 
Primer Name Sequence (5’-3’) PCR Conditions 
M-481 ACAGATTGCTGATTCCCAGCA 57°C annealing 
35 cycles M-915R TATTCTTCCCTCATAGACTC 
SW-H1-1 CAGGGGAAAATAAAAGCAACCAAAATG 59°C annealing 
35 cycles SW-H1-970R GACATTCTCCAATTGTGACTGGATG 
H3-1151 TAGACGGTTGGTACGGTTTCAGG 59°C annealing 
40 cycles H3-1609R ACCGGTTGTTTAATGCTTCGTCTC 
MN-PA-206 TTGAAGGGAGGGACCGGAAT 57°C annealing 
35 cycles MN-PA-410R ATATGGATGTGCGTACCT 
MN-PB2-1363 TTGGGATACTCCCTGATTTA 50°C annealing 
40 cycles MN-PB2-1569R TTATCGTTAACCTTTCATTC 
NC-PA-762 ACGTCCCCTCAGATTGCCT 57°C annealing 
35 cycles NC-PA-1070R CACTTCAATTGGCTTGTTC 
NC-PB2-1540 GACACAAGGAACGGAGAAGT 59°C annealing 
40 cycles NC-PB2-1792R TTTGCTGGAACAGTGTCCTT 
 
Note:  Nucleotides in bold differ from A/TX/6/96 sequence. 
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1% agarose gel containing Gel Red.  The discriminatory primers chosen for SW/MN/99 
were MN-PA-206F with MN-PA-410R and MN-PB2-1363F with MN-PB2-1569R.  
SW/MN/99 PA primers were specific after 35 cycles with an annealing temperature of 
57°C and SW/MN/99 PB2 primers were specific after 40 cycles with an annealing 
temperature of 50°C.  The discriminatory primers chosen for SW/NC/02 were NC-PA-
762F with NC-PA-1070R, and NC-PB2-1540F with NC-PB2-1792F.  SW/NC/02 PA 
primers were specific for SW/NC/02 after 35 cycles with an annealing temperature of 
57°C and SW/NC/02 PB2 primers were specific for SW/NC/02 after 35 cycles with an 
annealing temperature of 59°C (Table 3-1). 
 
 
Detection of Reassortant Viruses.  After RNA was extracted from the cell 
supernatants, an RT-PCR was run with M gene specific primers to determine sample 
quality.  The PCR was run for 35 cycles using a 57°C annealing temperature.  RT-PCR 
with H1 specific primers was run to confirm that no H1 viruses were present in the 
samples.  These reactions were run for 40 cycles with a 59°C annealing temperature.  RT-
PCR with H3 specific primers was run to confirm the presence of H3 in the samples and 
was run for 40 cycles with a 59°C annealing temperature.  PA and PB2 reactions were 
run using the optimal conditions previously described.  PCR products were visualized on 
a 1% agarose gel containing Gel Red. 
 
 
Results 
 
 
 No Detectable Reassortment of a Classical Swine H1N1 Virus.  To determine 
the ability of a classical swine H1N1 influenza virus to successfully acquire a human H3 
gene, MDCK cells were co-infected with the classical swine lineage virus SW/MN/99 
and the human influenza virus TX/96.  The cells were incubated at 37°C or 39°C and 
supernatants were collected 48 hours post-infection.  The supernatants were then 
incubated with swine serum raised against SW/MN/99 to neutralize any viruses 
containing the classical swine H1 and used to inoculate MDCK cells which were then 
incubated for 48 hours.  RNA was extracted from the cell supernatants and five RT-PCR 
reactions were performed to detect M, H1, H3, swine PA, and swine PB2.  Of the 61 
samples collected, 44 were PCR positive for M, indicating the presence of virus in the 
sample (Figure 3-3).  One sample was PCR positive for H1 (Figure 3-4), indicating that 
neutralization was incomplete in that sample.  38 of the M positive samples were PCR 
positive for H3 (Figure 3-5), and an additional 10 samples in which M was not detected 
were also positive for H3.  Of the 48 samples that were positive for H3, none were 
positive for SW/MN/99 PA or PB2 (Figures 3-6 and 3-7), indicating that SW/MN/99 was 
not able to successfully acquire the human H3 gene under any of the tested conditions 
and that the H3 viruses detected were likely wholly TX/96. 
 
 
High Frequency of Reassortment of a Reassortant Swine H1N1 Virus.  To 
determine the ability of a triple reassortant swine H1N1 influenza virus to successfully  
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Figure 3-3.  M Gene PCR on TX/96 + SW/MN/99 Co-infection Supernatants.  
MDCK cells were co-infected with TX/96 and SW/MN/99.  Forty-eight hours post-
infection, the tissue culture media was collected and incubated with swine sera raised 
against SW/MN/99.  The neutralized supernatants were then used to infect MDCK cells 
and the cells were incubated for 48 hours.  RNA was extracted from the cell supernatants 
and one-step RT-PCR was performed using M gene specific primers.  All products were 
run on a 1% agarose gel containing Gel Red. 
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Figure 3-4.  H1 Gene PCR on TX/96 + SW/MN/99 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using H1 specific primers and products were visualized on a 1% agarose 
gel containing Gel Red. 
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Figure 3-5.  H3 Gene PCR on TX/96 + SW/MN/99 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using H3 specific primers and products were visualized on a 1% agarose 
gel containing Gel Red. 
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Figure 3-6.  PA Gene PCR on TX/96 + SW/MN/99 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using SW/MN/99 PA specific primers and products were visualized on a 
1% agarose gel containing Gel Red. 
 
 
 
 
37 
 
 
 
Figure 3-7.  PB2 Gene PCR on TX/96 + SW/MN/99 Co-infection Supernatants.  
RNA was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-
PCR was performed using SW/MN/99 PB2 specific primers and products were visualized 
on a 1% agarose gel containing Gel Red. 
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acquire a human H3 gene, MDCK cells were co-infected with the reassortant swine virus 
SW/NC/02 and the human influenza virus TX/96.  The cells were incubated at 37°C or 
39°C and supernatants were collected 48 hours post-infection.  The supernatants were 
then incubated with swine serum raised against SW/NC/02 to neutralize any H1 viruses 
and the neutralized supernatants were used to inoculate MDCK cells.  The cells were 
incubated for 48 hours and then RNA was extracted from the cell supernatants.  
Following RNA extraction, five RT-PCR reactions were performed to detect M, H1, H3, 
avian-like swine PA, and avian-like swine PB2.  Of the 63 samples collected, 51 were 
PCR positive for M (Figure 3-8).  None of the samples were PCR positive for H1 (Figure 
3-9).  31 of the M positive samples were also positive for H3 (Figure 3-10), and 7 
samples were negative for M but positive for H3.  Of the 38 samples that were positive 
for H3, 20 (53%) contained both PA and PB2 from SW/NC/02 and 11 (29%) contained 
only PA from SW/NC/02 (Figures 3-11 and 3-12).  An additional 20 samples were 
positive for M but negative for H3.  Nine of these samples contained both PA and PB2 
from SW/NC/02 and 11 contained PA from SW/NC/02.  Although these samples were 
negative for H1, without a positive H3 PCR, reassortment cannot be confirmed. 
 
 
 Optimal Conditions for Human/Swine Virus Reassortment.  Cells were co-
infected at a range of MOIs, from 5 to 0.01, and incubated at two temperatures to 
determine if there were optimal conditions for the in vitro reassortment of swine 
influenza viruses.  Inoculations with the human and swine viruses were also staggered to 
determine if this affected reassortment frequency.  The conditions under which cells were 
infected and incubated had varying effects on the frequency of successful reassortment.  
When cells were co-infected simultaneously and incubated at 37°C, 10 of the collected 
samples contained reassortants (Figure 3-13A).  More reassortants were detected in 
samples which were inoculated with TX/96 at an MOI of 1 or 5, but the MOI of 
SW/NC/02 did not appear to have an effect.  In contrast, when cells were infected with 
TX/96 24 hours after infection with SW/NC/02 and incubated at 37°C, only four samples 
contained reassortants (Figure 3-13B).  Under these conditions, the MOI of TX/96 did 
not affect the frequency of reassortment, but three of the four samples where reassortants 
were detected had been inoculated with SW/NC/02 at an MOI=0.1.  When cells were co-
infected simultaneously and incubated at 39°C, seven samples contained reassortants 
(Figure 3-13C).  Once again, while the MOI of TX/96 did not appear to affect the 
frequency of reassortment, five of the seven samples in which reassortants were detected 
had been inoculated with SW/NC/02 at an MOI=1 or 0.1.  When cells were infected with 
TX/96 24 hours after infection with SW/NC/02 and incubated at 39°C, reassortants were 
detected in nine samples (Figure 3-13D).  In contrast to the other conditions tested, the 
MOI of both TX/96 and SW/NC/02 affected the frequency with which reassortants were 
detected, with reassortants most frequently detected in samples with high TX/96 MOIs 
and low SW/NC/02 MOIs. 
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Figure 3-8.  M Gene PCR on TX/96 + SW/NC/02 Co-infection Supernatants.  MDCK 
cells were co-infected with TX/96 and SW/MN/99.  Forty-eight hours post-infection, the 
tissue culture media was collected and incubated with swine sera raised against 
SW/NC/02.  The neutralized supernatants were then used to infect MDCK cells and the 
cells were incubated for 48 hours.  RNA was extracted from the cell supernatants and 
one-step RT-PCR was performed using M gene specific primers.  All products were run 
on a 1% agarose gel containing Gel Red. 
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Figure 3-9.  H1 Gene PCR on TX/96 + SW/NC/02 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using H1 specific primers and products were visualized on a 1% agarose 
gel containing Gel Red. 
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Figure 3-10.  H3 Gene PCR on TX/96 + SW/NC/02 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using H3 specific primers and products were visualized on a 1% agarose 
gel containing Gel Red. 
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Figure 3-11.  PA Gene PCR on TX/96 + SW/NC/02 Co-infection Supernatants.  RNA 
was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-PCR 
was performed using SW/NC/02 PA specific primers and products were visualized on a 
1% agarose gel containing Gel Red. 
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Figure 3-12.  PB2 Gene PCR on TX/96 + SW/NC/02 Co-infection Supernatants.  
RNA was extracted from the cell supernatants of co-infected MDCK cells.  One-step RT-
PCR was performed using SW/NC/02 PB2 specific primers and products were visualized 
on a 1% agarose gel containing Gel Red. 
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Figure 3-13.  Conditions under Which Reassortant Viruses Were Detected.  37°C, 
No delay (A).  37°C, TX/96 delayed 24 hours (B).  39°C, No delay (C).  39°C, TX/96 
delayed 24 hours (D).  Samples which were positive for H3 and containing SW/NC/02 
PA and PB2 are shown in green.  Samples positive for H3 and containing SW/NC/ PA 
are shown in yellow.  Samples positive for H3 but negative for both SW/NC/02 PA and 
PB2 are shown in blue.  Samples that were negative for H3 are in white. 
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Figure 3-13 (continued).   
 
 
47 
Discussion 
 
 The ability of reassortant swine influenza A viruses to readily acquire novel HA 
genes raises the possibility of the introduction of novel HA subtypes into both the swine 
and human populations.  Co-infection of MDCK cells with a human H3N2 virus and a 
classical swine H1N1 virus did not result in any detectable reassortant viruses containing 
the human H3 with the swine PA or PB2.  There are several possible explanations for this 
lack of detectable reassortment.  The successful reassortment of two influenza A viruses 
is dependent on infection, replication, packaging, and fitness.  While it is assumed that in 
tissue culture both viruses will be able to enter the same cells, this has not been 
demonstrated and therefore exclusion of one of the viruses by the other remains a 
possibility.  The detection of H3 in 48 of the 61 samples suggests that if exclusion did 
take place, it was exclusion of SW/MN/99 by TX/96.  Since this virus has a very similar 
HA and NA to that of SW/NC/02, which was readily able to undergo reassortment, this 
explanation is not likely. 
 
 Once both viruses have entered the cell, their genomes must both be replicated.  
Viruses lacking a functional polymerase complex can be rescued by co-infection with a 
helper virus, showing that the polymerase from one virus can replicate the genome of 
another.  The genes of TX/96 may be preferentially replicated over those of SW/MN/99, 
although the amount of each parental virus produced was not determined.  Previous 
studies of co-infection using a classical swine and an avian influenza virus showed that 
replication of the avian virus interfered with the replication of the swine virus (118).  It is 
also possible that reassortant viruses were created, but were less fit than the parental 
TX/96 virus and therefore had been overgrown by 48 hours post-infection.  Samples 
taken at earlier timepoints may allow for detection of these populations.  The double 
reassortant H3N2 lineage, which contained HA, NA, and PB1 genes from a TX/96-like 
virus was not able to become established in the swine population, supporting the theory 
that a reassortant between a classical swine virus and a human virus has no advantage 
over the parental strains. 
 
In contrast to the lack of detectable reassortment between TX/96 and SW/MN/99, 
co-infection of MDCK cells with a human H3N2 virus and a triple reassortant swine 
H1N1 virus resulted in a high frequency of reassortant viruses containing human H3 with 
avian-origin swine PA or PB2.  While fewer samples were positive for the H3 gene, 82% 
of the samples which were positive for the human H3 gene were also positive for 
SW/NC/02 PA or PB2.  Under a range of conditions, TX/96 and SW/NC/02 were able to 
enter, replicate, and be packaged in the same cells and the resulting reassortant viruses 
had an advantage over the parental strains.  This is supported by the fact that triple 
reassortant swine influenza viruses quickly replaced the classical H1N1 lineage in North 
American swine.  Both the 1957 and 1968 pandemic viruses involved the introduction of 
both HA and PB1 from an avian lineage, and both the double and triple reassortant swine 
influenza viruses contained HA and PB1 from the same human lineage, suggesting that 
compatibility between HA and PB1 might also be required for successful reassortment. 
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These results correspond well with surveillance data that show the classical swine 
H1N1 lineage was stable in the North American swine population for close to 80 years, 
while novel triple reassortant lineage swine viruses continue to emerge (23,143).  The 
presence of avian-origin internal genes appears to be advantageous to swine influenza 
viruses, as swine influenza viruses in Europe have contained avian-origin internal genes 
since the introduction of a wholly-avian virus into the swine population in 1979 (108).  
These viruses have undergone multiple reassortment events resulting in viruses which 
maintain the avian-origin internal genes but acquire new HA and NA genes (13,11,88). 
 
 MDCK cells are derived from canine kidney epithelial cells.  While they are a 
widely used in vitro model for the growth and characterization of influenza A viruses, 
and contain both α-2,3 and α-2,6 sialyloligosaccharides on their surface, they are not 
swine in origin and are not a respiratory cell line.  Therefore they may differ from swine 
respiratory cells in receptors, cytokines, and growth factors.  Co-infection of a swine 
respiratory cell line was attempted, but the viruses did not grow to sufficient titers to 
analyze.  A549 cells, which are a human respiratory epithelial cell line, as well as a 
recently developed primary swine tracheal culture, may provide more insight into 
reassortment in the respiratory tract. 
 
The temperature of incubation, amount of virus inoculum, and the timing of co-
infection all influenced the successful generation of reassortant viruses in vitro, although 
no overall pattern was observed.  When cells were incubated at 37°C, delaying infection 
with TX/96 decreased the number of reassortants detected, possibly due to the viruses not 
being replicated and packaged at the same time.  The samples which did contain 
reassortants had been infected with SW/NC/02 at an MOI=0.1 or 0.01, which would 
allow for multiple rounds of replication of SW/NC/02 and a higher probability of being 
replicated in a cell that was also been infected with TX/96.  In contrast, when cells were 
incubated at 39°C, delaying infection with TX/96 was not detrimental to the generation 
of reassortant viruses.  The avian-origin polymerase complex has been shown to be more 
efficient at higher temperatures (8) and therefore viruses which contain the avian PA and 
PB2 would be more fit than the wholly TX/96 virus at 39°C. 
 
 More understanding of the mechanisms controlling influenza reassortment is 
important because pigs are capable of transmitting influenza to humans, and the dominant 
viruses circulating in the swine population are able to acquire novel HA genes and 
potentially introduce novel viruses into the human population.  Previous studies on 
influenza viral reassortment have shown that certain gene segments tend to reassort 
together (31,82), but that HA and NA are able to reassort independently (112).  The 
independent reassortment of HA and NA possibly evolved as an immune evasion 
mechanism for the virus.  Recent reassortment between a triple reassortant lineage virus 
and the Eurasian swine H1N1 lineage led to the first human influenza pandemic of the 
21st century (33).  It is possible that the TRIG cassette is more compatible with a broader 
range of HA and NA genes than classical swine viruses, therefore allowing increased 
reassortment, or that increased activity of the polymerase complex of the TRIG cassette 
causes viruses containing these genes to be more fit that the parental viruses.  Further 
studies, including the reverse genetics generation of single gene reassortant viruses, 
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quantitative detection of reassortants, and in vivo co-infections are necessary to elucidate 
the mechanisms controlling the acquisition of novel HA genes by triple reassortant swine 
influenza viruses. 
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CHAPTER 4: CHARACTERIZATION OF NORTH AMERICAN SWINE 
INFLUENZA A VIRUSES 
 
 
Introduction 
 
The evolution of swine influenza viruses in North America has been distinct from 
that in Europe or Asia (10).  Prior to 1998, the majority of swine influenza in North 
America was caused by H1N1 viruses of the classical swine lineage.  These viruses were 
highly stable, both genetically and antigenically, and caused low levels of morbidity and 
mortality in swine herds.  Serological studies performed on pig sera collected between 
1988 and 1989 showed that 31% of samples were positive for antibodies against classical 
H1N1 swine viruses, but only 1.1% were positive for antibodies against a contemporary 
human H3N2 virus (18).  These numbers were similar to studies conducted on swine sera 
from 1976 and 1977 (50).  However, when serological studies were performed on sera 
collected from pigs between 1997 and 1998, the number of samples positive for 
antibodies against a contemporary human H3N2 virus had risen to 8% (106).  In 1998, 
two reassortant H3N2 influenza A viruses were isolated from four swine herds in North 
America.  The virus isolated from one of the swine herds was classified as a double 
reassortant H3N2 virus and contained the HA, NA and PB1 gene segments from a 
human-origin H3N2 virus and the remaining gene segments from the classical swine 
H1N1 lineage.  The virus isolated from the other three swine herds was a triple 
reassortant virus that contained the HA, NA, and PB1 gene segments from a human-
origin H3N2 virus, the M, NP, and NS gene segments from a classical swine-origin 
H1N1 virus, and the PA and PB2 gene segments from an avian-origin virus (160).  This 
triple reassortant virus quickly became established in the North American swine 
population (149) and continued to reassort with other circulating viruses (83,149,142,58).  
The reassortant swine influenza viruses also replaced the previously circulating classical 
swine H1N1 lineage and these viruses are no longer isolated from North American swine 
(143). 
 
Once established in the swine population, viruses of the triple reassortant lineage 
continued to evolve, picking up novel HA genes while maintaining their internal gene 
constellation (83,149,142,58).  As shown in Chapter 3, swine influenza viruses 
containing the TRIG cassette are more capable of acquiring novel HA genes than 
classical swine influenza viruses.  However, little is known about the reasons for the 
increased fitness of these triple reassortant viruses in pigs and why they were able to 
replace the long dominant classical H1N1 swine influenza lineage.  The rapid appearance 
of the triple reassortant swine influenza viruses and their high capacity for reassortment 
indicate that they may pose a pandemic threat to the human population. Furthermore, the 
high rate of reassortment may indicate unique characteristics of the TRIG cassette in 
terms of reassortment ability and compatibility with various HA and NA genes. 
 
Several factors have been shown to influence the success of influenza A viruses in 
different hosts, including the polymerase complex and the surface glycoproteins.  The 
polymerase complex genes PB2, PB1, and PA, none of which are of classical swine 
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origin in the TRIG cassette, have been shown to play a role in the generation of 
reassortant viruses, as well as in replication efficiency, host range restriction, temperature 
sensitivity, and viral pathogenesis (42,147,76,90).  The surface glycoproteins are a major 
determinant of host range restriction (2) and have also been shown to affect the 
temperature sensitivity of viral replication(122).  The fitness of the triple reassortant 
swine virus lineage and its ability to continue to reassort compared to that of the double 
reassortant swine virus, which contains the human-origin PB1, but classical swine origin 
PA and PB2, suggests a role of the PA and PB2 genes in allowing for successful 
reassortment and maintenance in pigs.  In order to begin to understand these properties, 
and to determine the influence of PA and PB2 on the replication and temperature 
sensitivity of swine influenza viruses, the replication kinetics of a classical and several 
reassortant swine influenza viruses were characterized in vitro through multi-step growth 
curves at several different temperatures reflecting replication sites of the swine 
respiratory tract.  To determine if the TRIG cassette confers a replicative advantage in 
vivo, pigs were infected with a classical swine H1N1 virus or a triple reassortant H1N1 
virus, and several triple reassortant swine viruses were characterized in ferrets to 
determine their pandemic potential in this animal model of human infection. 
 
 
Materials and Methods 
 
 
Viruses Used.  Four swine influenza A viruses were characterized in vitro.  
SW/MN/37866/99 (SW/MN/99) is a classical swine H1N1 virus (Figure 4-1A).  
SW/NC/18161/02 (SW/NC/02) is a triple reassortant swine H1N1 virus with classical 
swine-origin HA, NA, M, NP, and NS genes, a human-origin PB1 gene, and avian-origin 
PA and PB2 genes (Figure 4-1B).  SW/NC/35922/98 (SW/NC/98) is a double reassortant 
swine H3N2 virus with human-origin HA and NA genes and classical swine-origin M, 
NP, NS, PA, and PB2 genes (Figure 4-1C), and SW/TX/4199-2/98 (SW/TX/98) is a 
triple reassortant swine H3N2 virus with human-origin HA, NA, and PB1 genes, classical 
swine-origin M, NP, and NS genes, and avian-origin PA and PB2 genes (Figure 4-1D).  
SW/MN/99 and SW/NC/02 were also characterized in pigs along with A/TX/6/96 
(TX/96), a human H3N2 virus that contains an HA and NA similar to those found in the 
original swine H3N2 reassortant viruses.  Three reassortant swine influenza A viruses 
were characterized in the ferret model, SW/NC/02, SW/TX/98, and SW/NC/38448-2/05 
(SW/NC/05) which is a triple reassortant H1N1 swine influenza virus with a human-
origin HA and NA.  SW/NC/98, SW/NC/02, and SW/NC/05 were obtained from Dr. 
Gene Erickson at the Rollins Animal Disease Laboratory and SW/TX/98 and SW/MN/99 
were obtained from Dr. Marie Gramer at the University of Minnesota Veterinary 
Diagnostic Laboratory. 
 
 
In Vitro Growth Curves.  MDCK cells were maintained in MEM supplemented 
with 5% fetal calf serum, vitamin solution, and antibiotic/antimycotic solution.  One day 
before infection, cells were trypsinized and seeded into 6-well tissue culture plates.  On 
the day of infection, viruses were diluted to an MOI=0.01 in MEM supplemented with  
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Figure 4-1.  Swine Viruses Characterized In Vitro.  Gene segments from the classical 
swine lineage are in green.  Gene segments from the human H3N2 lineage are in blue.  
Gene segments from the avian lineage are in yellow.  (A) SW/MN/99.  (B) SW/NC/02.  
(C) SW/NC/98.  (D) SW/TX/98. 
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bovine serum albumin, vitamin solution, and antibiotic/antimycotic solution.  Cells were 
washed once with infection media and the diluted virus was added.  Plates were 
incubated at 4°C for 30 minutes to synchronize the infection, and then were incubated at 
the appropriate temperature (33°C, 35°C, or 39°C) for 1 hour.  After incubation, cells 
were washed twice with 0.9% NaCl pH2.2 and then twice with sterile PBS.  Cells were 
overlayed with MEM containing 2ug/ml L-(tosylamido-2-phenyl) ethyl chloromethyl 
ketone (TPCK)-trypsin and incubated at 33°C, 35°C, or 39°C.  Supernatants were 
collected at 12, 24, and 48, hours post-infection and viral titers were determined by 
TCID50.  All infections were done in triplicate wells. 
 
 
Swine Infections.  Influenza negative pigs were obtained from Midwest Research 
Swine (Gibbon, MN).  Infectivity and transmissibility of SW/MN/99, SW/NC/02, and 
TX/96 were tested in four 4 week-old outbred pigs.  For each virus, two pigs were 
anesthetized with ketamine and xylazine and inoculated intranasally with 104 plaque 
forming units (PFU) of virus.  Twenty-four hours post-infection, one naïve contact 
animal was housed with each infected animal.  Nasal swabs were taken daily through day 
10 post-infection and viral titers were determined by TCID50. 
 
 
Ferret Infections.  Influenza A negative ferrets were obtained from the ferret 
breeding program at St. Jude Children’s Research Hospital (Memphis, TN) or from 
Triple F Farms (Sayre, PA).  Infectivity and transmissibility of each influenza virus were 
tested in six 3-4 month old ferrets per virus under BSL-2 conditions.  Three ferrets were 
anesthetized with isofluorane and inoculated intranasally with 106 TCID50 SW/NC/02, 
SW/NC/05, or SW/TX/98 diluted in PBS.  Twenty-four hours post-inoculation, one naïve 
contact animal was housed with each infected animal.  At days 1, 4, 7 and 11 post-
inoculation, animals were anesthetized with ketamine and nasal washes were collected. 
The nasal washes were titrated in embryonated hen eggs and the EID50 was determined. 
 
 
Hemagglutination Inhibition (HI) Assays.  Serum samples were collected from 
swine and ferrets at 21 days post-infection and treated with Vibrio cholerae receptor-
destroying enzyme (Denka-Sekien, Tokyo, Japan) followed by heat inactivation at 56°C 
for 30 minutes prior to serological testing.  Sera were titrated in round bottom 96-well 
plates and incubated for 45 minutes at room temperature with four agglutinating doses of 
homologous virus.  A 0.5% solution of turkey red blood cells was then added and 
incubated at room temperature for 30 minutes.  HI titer was determined based on the 
highest dilution of sera which caused complete inhibition of red blood cell agglutination. 
 
 
Results 
 
 
Reassortant Swine Viruses Have Improved Growth Kinetics at Early 
Timepoints.  To determine if viruses containing the TRIG cassette had a replicative 
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advantage over double reassortant and classical swine influenza viruses, MDCK cells 
were infected in triplicate with 0.01 MOI of virus and incubated at 35°C, the standard 
temperature used for isolation and growth of influenza A viruses in cell culture.  
Supernatants were collected at 12, 24, and 48 hours post-infection and viral titers were 
determined by TCID50.  The triple reassortant H3N2 virus, SW/TX/98, had the highest 
titers at all timepoints (p<0.01), with an average titer of 105.44 TCID50/ml at 12 hours 
post-infection, an average titer of 106.1 TCID50/ml at 24 hours post-infection, and an 
average titer of 105.92 TCID50/ml at 48 hours post-infection (Figure 4-2).  The triple 
reassortant H1N1 swine virus, SW/NC/02, had an average titer of 103.22 TCID50/ml at 12 
hours post-infection, an average titer of 104.7 TCID50/ml at 24 hours post-infection, and 
an average titer of 104.33 TCID50/ml at 48 hours post-infection.  The double reassortant 
H3N2 swine virus, SW/NC/98, had an average titer of 104.5 TCID50/ml at 12 hours post-
infection, an average titer of 105 TCID50/ml at 24 hours post-infection, and an average 
titer of 104.1 TCID50/ml at 48 hours post-infection.  The classical H1N1 swine virus, 
SW/MN/99, had no detectable titer at 12 hours post-infection, an average titer of 104.1 
TCID50/ml at 24 hours post-infection, and an average titer of 105 TCID50/ml at 48 hours 
post-infection. 
 
At 12 hours post-infection, the average titer of each virus was significantly 
different from all others (p<0.01), with the triple reassortant H3N2 virus attaining the 
highest titer, followed by the double reassortant H3N2 and the triple reassortant H1N1.  
At 24 and 48 hours post-infection, the difference in titers between the classical H1N1 and 
the triple reassortant H1N1, as well as the difference in titers between the triple 
reassortant H1N1 and the double reassortant H3N2 were not significantly different from 
each other, while the difference in titers between the classical H1N1 and the double 
reassortant H3N2 was statistically significant (p<0.01). 
 
 
Swine Viruses Differ in Temperature Sensitivity In Vitro.  Previously, we 
found that a triple reassortant H3N2 virus grew faster than a classical H1N1 virus at 
35°C.  This could lead to a growth advantage in the respiratory tract.  To determine if the 
TRIG cassette altered the temperature sensitivity of swine influenza viruses, multi-step 
growth curves were performed at 33°C or 39°C, corresponding to the temperatures of the 
proximal and distal respiratory tract of pigs (73). 
 
At 33°C, the triple reassortant H1N1 and H3N2 viruses had similar titers at 12 
hours post-infection, 103.83 TCID50/ml and 104.11 TCID50/ml, respectively, which were 
higher (p<0.001) than the average titer of the double reassortant virus, which was 102.67 
TCID50/ml (Figure 4-3A).  However, by 24 hours post-infection the triple reassortant 
H3N2 virus had an average titer of 106.22 TCID50/ml, which was higher than any of the 
other viruses (p<0.01).  Although the double reassortant H3N2 had a lower average titer 
at 12 hours post-infection, by 24 hours post-infection it had an average titer of 105.53 
TCID50/ml, higher than the average titer of the triple reassortant H1N1 virus which was 
104.44 TCID50/ml (p<0.001).  At both 24 and 48 hours post-infection, the triple reassortant 
H3N2 virus had the highest titers, followed by the double reassortant H3N2 virus, the  
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Figure 4-2.  Replication of Swine Influenza A Viruses at 35°C.  MDCK cells were 
infected with 0.01 MOI of virus and incubated at 35°C.  Supernatants were periodically 
collected and viral titers determined by TCID50.  All bars represent the mean of 3 wells 
plus SEM.  SW/MN/99 is a classical swine H1N1 virus; SW/NC/02 is a triple reassortant 
H1N1 virus; SW/NC/98 is a double reassortant H3N2 virus; and SW/TX/98 is a triple 
reassortant H3N2 virus. 
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Figure 4-3.  Replication of Swine Influenza A Viruses at 33°C and 39°C.  MDCK 
cells were infected with 0.01 MOI of virus and incubated at 33°C (A) or 39°C (B).  
Supernatants were collected and viral titers were determined by TCID50.  All bars 
represent the mean of triplicate wells plus SEM. 
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triple reassortant H1N1 virus, and the classical swine H1N1 virus, and all of the titers 
were significantly different from each other (p<0.05). 
 
At 39°C, the triple reassortant H3N2 virus had a slightly higher titer (104.6 
TCID50/ml) than the triple reassortant H1N1 virus (103.97 TCID50/ml) at 12 hours post-
infection, although this difference was not statistically significant (Figure 4-3B).  The 
titers of both viruses were significantly higher than that of the double reassortant H3N2 
(103.1 TCID50/ml, p<0.01).  At 24 hours post-infection, the triple reassortant virus had an 
average titer of 105.56 TCID50/ml, which was significantly higher than that of the other 
viruses.  The titer of the triple reassortant H1N1 virus (104.25 TCID50/ml) was not 
significantly different from that of the double reassortant H3N2 virus (103.81 TCID50/ml), 
but was significantly higher than the titer of the classical H1N1 virus (103.33 TCID50/ml, 
p<0.01).  At 48 hours post-infection, all of the titers were significantly different from 
each other with the exception of the classical swine H1N1 and double reassortant H3N2 
viruses.  The triple reassortant H3N2 virus had the highest average titer, 104.61 
TCID50/ml, followed by the triple reassortant H1N1 virus with an average titer of 103.58 
TCID50/ml, the double reassortant H3N2 virus with an average titer of 102.94 TCID50/ml, 
and the classical H1N1 virus with an average titer of 102.5 TCID50/ml. 
 
A 12 hour replication delay was observed for the classical H1N1 virus 
SW/MN/99 at both temperatures (Figure 4-3), similar to what was observed at 35°C.  The 
lower temperature of 33°C did not have a significant effect on SW/MN/99 titers at 24 
hours post-infection (Figure 4-4A), but the average titer was 24.5% lower at 48 hours 
post-infection (p<0.001).  At 39°C, viral titers were reduced by 18.7% at 24 hours post-
infection (p<0.05), and 50% at 48 hours post-infection (p<0.001).  The double reassortant 
H3N2 and triple reassortant H3N2 viruses showed similar patterns of temperature 
sensitivity that were distinct from that of the triple reassortant H1N1 (Figure 4-4).  Both 
the double and triple reassortant H3N2 viruses had lower titers at 39°C than at 35°C 
across all timepoints, with an average decrease of 25.7% (p<0.001) for the double 
reassortant H3N2 virus, and 15.5% (p<0.05) for the triple reassortant H3N2 virus.  At 
39°C, the double and triple reassortant H3N2 viruses each had a decrease at 12 hours 
post-infection versus 35°C, but an increase in titer by 48 hours post-infection.  The triple 
reassortant H1N1 virus had no significant difference in titers between 33°C and 35°C at 
any timepoint, and a 23.4% increase (p<0.05) in viral titer at 39°C compared to 35°C at 
12 hours post-infection.   
 
 
A Human H3N2 Influenza A Virus Inefficiently Infects Swine.  To determine 
if a human H3N2 virus was able to infect and transmit between swine and therefore be 
available for reassortment with circulating swine influenza viruses, two influenza free 
pigs were inoculated intranasally with 104 PFU of TX/96, which has an HA and NA 
similar to those found in the original triple reassortant swine viruses.  Each inoculated pig 
had a contact pig housed with it 24 hours post-inoculation and nasal swabs were collected 
daily to determine viral titers in each pig.  Both of the inoculated pigs began to shed virus 
by day two post-inoculation with an average titer of 103.63 TCID50/ml.  They continued to 
shed virus until day six post-inoculation (Figure 4-5).  One of the two contact animals  
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Figure 4-4.  Effect of Temperature on Growth of Swine Influenza A Viruses.  (A) 
Classical swine H1N1 virus, SW/MN/99.  (B) Triple reassortant swine H1N1 virus, 
SW/NC/02.  (C) Double reassortant swine H3N2 virus, SW/NC/98.  (D) Triple 
reassortant swine H3N2 virus, SW/TX/98. 
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Figure 4-5.  Growth and Transmission of a Human H3N2 Virus in Pigs.  Two pigs 
were inoculated intranasally with 104 PFU of TX/96.  Twenty-four hours post-
inoculation, one naïve pig was housed with each infected pig.  Nasal swabs were 
collected daily for ten days post-infection and viral titers were determined by TCID50. 
 
 
60 
had a nasal titer of 103 TCID50/ml at day six post-contact and continued to shed virus 
through day nine with a peak titer of 103.67 TCID50/ml at day seven post-contact.  The 
second contact pig did not shed detectable amounts of virus and did not seroconvert.  
None of the pigs showed any clinical disease symptoms. 
 
 
 A Reassortant H1N1 Swine Virus Does Not Have an Advantage over a 
Classical H1N1 Swine Virus in the Nasal Cavity of Swine.  Following the emergence 
of triple reassortant swine viruses, classical H1N1 viruses quickly disappeared from the 
swine population.  To determine if the triple reassortant H1N1 swine virus had a 
replication advantage over the classical H1N1 swine virus in pigs that would explain its 
ability to replace the classical H1N1 lineage in the swine population, two pigs were 
inoculated intranasally with 104 PFU of SW/MN/99 or SW/NC/02.  Each infected pig had 
a contact pig housed with it 24 hours post-inoculation and nasal swabs were collected 
daily.  One of the pigs infected with SW/MN/99 began to shed virus to a titer of 102.25 
TCID50/ml at day one post-inoculation, and shed virus until day six, with a peak titer of 
104.75 TCID50/ml at day four (Figure 4-6A).  The other inoculated pig did not shed 
detectable levels of virus until day four post-inoculation with a titer of 102.83 TCID50/ml 
and only shed virus for three days.  The contact pig housed with the pig that began to 
shed virus on day one shed virus beginning on day three post-contact and continuing 
through day seven post-contact, with a peak titer of 105.5 TCID50/ml at day five post-
contact.  The other contact pig shed virus from day four through day six post-contact, 
with a peak titer of 104 TCID50/ml.  All four pigs seroconverted and none showed clinical 
symptoms.  Both of the pigs inoculated with SW/NC/02 began to shed virus by day two 
post-inoculation, with an average titer of 103.67 TCID50/ml and continued to shed virus 
through day six or day seven with an average peak titer of 104.38 TCID50/ml (Figure 4-
6B).  The two contact pigs began to shed virus at day four post-contact, with an average 
titer of 103 TCID50/ml.  One contact pig shed through day seven post-contact with a peak 
titer of 104.75 TCID50/ml and the other shed virus through day nine post-contact with a 
peak titer of 103.67 TCID50/ml.  All four pigs seroconverted but none showed clinical 
symptoms.  
 
 
  Triple Reassortant Lineage Swine Influenza Viruses Can Replicate and 
Transmit in Ferrets.  The HA protein has been shown to affect replication and 
transmission of influenza A viruses in several animal models.  The replication and 
transmission of a triple reassortant H3N2 swine virus, a triple reassortant H1N1 virus 
with human-origin HA and NA and a triple reassortant H1N1 virus with swine-origin HA 
and NA were characterized in ferrets.  Three ferrets were inoculated intranasally with 106 
TCID50 of the triple reassortant H3N2 SW/TX/98, 106 TCID50 of SW/NC/02, which has 
swine-origin HA and NA or 106 TCID50 of SW/NC/05, which has human-origin HA and 
NA.  Each inoculated ferret had a contact ferret housed with it and nasal washes were 
collected on days 1, 4, 7, and 11 post-infection.  All three of the ferrets inoculated with 
SW/TX/98 shed detectable levels of virus by day one post-inoculation, with an average 
titer of 105.17 EID50/ml (Figure 4-7).  The three contact animals all shed virus by day three 
post-contact, although there was variability in the amount of virus shed between animals,  
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Figure 4-6.  Growth and Transmission of Classical and Reassortant Swine H1N1 
Viruses in Pigs.  Two pigs were infected intranasally with 104 PFU of SW/MN/99 or 
SW/NC/02.  Twenty-four hours post-inoculation, one naïve animal was housed with each 
infected animal.  Nasal swabs were collected daily for 10 days post-infection and viral 
titers were determined by TCID50. 
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Figure 4-7.  Growth and Transmission of a Triple Reassortant Swine H3N2 Virus in 
Ferrets.  Three ferrets were inoculated intranasally with 106 TCID50 of SW/TX/98.  
Twenty-four hours post-inoculation, one naïve ferret was housed with each infected 
ferret.  Nasal washes were collected 1, 4, 7, and 11 days post-infection and viral titers 
were determined by EID50. 
 
 
 
63 
with titers ranging from 102.75 EID50/ml to 105.5 EID50/ml.  The contact ferret that had the 
lowest viral titer on day three post-contact did not continue to shed virus, and did not 
seroconvert.  Two of the three ferrets inoculated with SW/NC/02 shed low levels of virus 
at day one post-inoculation, with an average titer of 102.63 EID50/ml, while the third ferret 
did not shed virus until day four, with a titer of 102.25 EID50/ml (Figure 4-8A).  None of 
the infected ferrets shed virus at a titer of more than 103 EID50/ml and all of the ferrets 
cleared the virus by day seven post-inoculation.  None of the three contact animals shed 
detectable levels of virus, although all three seroconverted, with HI titers similar to 
infected ferrets.  Ferrets inoculated with SW/NC/05 shed high levels of virus beginning at 
day one post-inoculation, with an average titer of 106.25 EID50/ml (Figure 4-8B).  The 
three contact ferrets shed high levels of virus at day three post-contact, with an average 
titer of 106.25 EID50/ml, and all seroconverted.  Ferrets infected with SW/TX/98 or 
SW/NC/05 lost an average of 8-10% of their starting body weight but did not show any 
other clinical symptoms such as sneezing, coughing, or lethargy. 
 
 
Discussion 
 
The emergence of the triple reassortant swine influenza virus lineage changed the 
dynamics of swine flu in North America.  Triple reassortant swine influenza viruses are 
more pathogenic than classical swine influenza viruses (105), and their continued rapid 
evolution through reassortment and antigenic drift makes vaccination difficult (141).  
Although double and triple reassortant swine influenza viruses were first isolated at 
approximately the same time, only the triple reassortant lineage successfully became 
established in the swine population (160,149).  In the years since they were first isolated, 
viruses of the triple reassortant lineage have supplanted classical swine influenza viruses 
and have acquired a number of novel HA and NA genes from circulating swine, human, 
and avian strains while maintaining the specific constellation of internal genes known as 
the TRIG cassette (143). 
 
Several factors have been shown to contribute to the success of influenza viruses 
in different hosts, including the surface glycoproteins, HA and NA (122), and the 
polymerase complex (78,147,119,42).  The polymerase complex of reassortant swine 
viruses appears to be a major determinant of their success.  Both the double and triple 
reassortant viruses are able to initiate replication more quickly than a classical swine 
influenza virus in MDCK cells, although samples taken at timepoints between 12 and 24 
hours post-inoculation are needed to determine the extent of the classical swine virus’s 
replication delay.  This advantage of the reassortant viruses in establishing infection may 
contribute to the success of the triple reassortant lineage in swine.  At 33°, which 
corresponds to the temperature of the nasal cavity of a pig, the two triple reassortant 
viruses had higher titers than the double reassortant virus at 12 hours post-infection, 
although this advantage is no longer seen at 24 hours post-infection.  At 39°C, which 
corresponds to the temperature of the lower respiratory tract of pigs, the triple reassortant 
viruses grew to higher titers than the double reassortant viruses at all timepoints. 
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Figure 4-8.  Growth and Transmission of Triple Reassortant H1N1 Swine Viruses in 
Ferrets.  Three ferrets were inoculated intranasally with 106 TCID50 of SW/NC/02 (A), 
which contains the HA and NA from the classical swine lineage, or SW/NC/05 (B), 
which contains the HA and NA from the human lineage.  Twenty-four hours post-
inoculation, one naïve contact animal was housed with each infected animal.  Nasal 
washes were collected 1, 4, 7, and 11 days post-inoculation and viral titers were 
determined by EID50. 
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The polymerase complex of influenza A viruses is heterotrimeric, composed of 
the PB2, PB1, and PA subunits.  PB1 forms the core of the complex, directly interacting 
with both PA and PB1.  Interestingly, although PA and PB2 are both of avian origin in 
the TRIG cassette, these two subunits have not been shown to directly interact with each 
other.  Prior studies have highlighted the importance of the PB2 protein in host-range 
restriction and temperature sensitivity of avian influenza viruses (87,90,71).  One amino 
acid in particular that has been shown to be important is at position 627.  In avian viruses, 
this residue is highly conserved as a glutamic acid (E), but in human viruses, it is a lysine 
(K). 
 
Position 627 does not reside in an identified functional domain or subunit binding 
site of the PB2 protein, but it is proposed to be involved in a conformational change 
which alters the ability of the complex to function in mammalian cells (94).  It has been 
shown that the replication of avian viruses is severely restricted in mammalian cells at 
lower temperatures when there is an E at position 627 of PB2, but that an E627K 
mutation abrogates this temperature sensitivity and is considered a necessary mutation for 
the successful establishment of an avian influenza virus in mammals (87).  Avian viruses 
containing the E627K mutation also have an increased ability to replicate in the nasal 
turbinates of mice (49).  Interestingly, the PB2 of triple reassortant swine viruses is of 
avian origin, and has retained an E at position 627, yet is still able to replicate in 
mammalian cells across a range of temperatures.  This suggests compensatory effects 
from other changes in the polymerase complex.  Chen, et al showed that an avian/human 
reassortant influenza virus containing an avian PB2 gene with human internal genes had a 
low rescue efficiency and formed small plaques.  However, when the human PA was 
replaced with an avian PA, the rescue efficiency and growth of the virus was improved 
(21), indicating that both the PA and PB2 of the triple reassortant lineage of swine 
influenza may be responsible for the enhanced replication efficiency across all tested 
temperatures. 
 
 At physiological temperatures (33°C and 39°C), triple reassortant swine influenza 
viruses have an early replicative advantage over other swine influenza viruses, and this 
advantage may explain their success in the swine population.  Reverse genetics studies 
with triple reassortant viruses containing only the PA or PB2 of avian origin will be 
necessary to determine if both genes are required for the success of the triple reassortant 
viruses.  Reassortant swine viruses also contain a human-origin PB1 which may play a 
role in their success.  This question could be addressed by replacing the human-origin 
PB1 gene with a classical swine-origin PB1 gene through reverse genetics. 
 
The replicative advantage of triple reassortant viruses in vitro was not observed in 
vivo.  Although one of the pigs infected with the classical H1N1 virus SW/MN/99 
showed a delayed onset of virus shedding and lower viral titers, we believe this to be due 
to a lack of initial infection and transmission of the virus between cubicles during nasal 
swabbing.  While the number of pigs used is low, this does not appear to represent a 
disadvantage of classical swine viruses, as the virus was able to establish successful 
infection in all four pigs.  However, experimental intranasal infection with low levels of 
virus does not mimic natural infection in pigs.  Intratracheal infection with high 
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inoculums is required to observe clinical symptoms, as much of the pathology is linked to 
viral titers in the lungs of infected pigs (105,139).  Lung pathology was not examined, 
and virus was not isolated from the trachea or bronchial tissue, so the viruses may differ 
in their replication in the lower respiratory tract.  Differences in viral fitness may only 
become apparent following the co-infection of pigs with both a classical and reassortant 
swine influenza virus. 
 
Along with the polymerase complex, the HA of influenza viruses plays an 
essential role in the success of a virus in a host.  Because ferrets show similar patterns of 
cell receptors and of clinical disease as humans when infected with influenza viruses 
(85,140), they are a good model to examine the potential threat of a novel influenza virus 
to the human population.  Three triple reassortant swine viruses which were used to 
inoculate ferrets showed different growth and replication kinetics.  SW/TX/98 and 
SW/NC/05, which both have human-origin HA and NA replicated to high titers and 
transmitted efficiently.  SW/NC/02, which has a classical swine lineage HA and NA, did 
not replicate as well in ferrets and contact ferrets did not shed virus, although they did 
seroconvert.  This contrasts with data from ferrets infected with the pandemic strain of 
H1N1, also a swine-origin reassortant influenza virus.  This virus also contains a classical 
swine-origin HA, yet it replicates and transmits efficiently in ferrets (86,96).  Viral titers 
were determined in eggs and the seroconversion of all contact ferrets with a lack of 
detectable viral titers, along with the low viral titers observed in infected animals may 
reflect a defect in the virus’s ability to replicate in eggs. 
 
The success of an influenza A virus in a particular host cannot be attributed to a 
single gene or protein, although the polymerase complex is a major determinant of viral 
fitness.  Through multiple reassortment events, the triple reassortant lineage of swine 
influenza A viruses obtained an internal gene constellation that has allowed it to become 
the dominant influenza lineage in North American swine.  While the specific mechanisms 
responsible for the generation and continued success of these viruses remain to be fully 
determined, it is clear that viruses belonging to this lineage have a replicative advantage 
over classical swine influenza viruses both in vitro and in vivo and will continue to pose a 
pandemic threat as they evolve. 
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CHAPTER 5: GENERAL DISCUSSION 
 
 
Swine are an important host in the ecology of influenza A viruses, as they are 
susceptible to both mammalian and avian influenza viruses and are able to transmit 
influenza to humans (52,64,97).  They have long been proposed as a mixing vessel for 
influenza A viruses, providing a host in which avian and mammalian origin viruses can 
exchange gene segments.  While no direct evidence exists to support the emergence of 
the 1957 and 1968 pandemic viruses from swine, the swine origin of the 2009 H1N1 
pandemic virus suggests a critical role for pigs in the generation of pandemic influenza 
viruses (33).   
 
Swine influenza viruses in North America have evolved rapidly since the 
introduction of the triple reassortant lineage in 1998, despite their stability for the 
previous 80 years (143).  The introduction of avian-origin gene segments appears to have 
a significant impact on the dynamics of influenza in swine, a situation observed both in 
Europe following the introduction of a wholly-avian strain (10), and in North America 
following the introduction of the triple reassortant lineage containing avian-origin PA and 
PB2 genes (143).  These studies examined the properties of reassortant swine influenza A 
viruses to better understand why they are able to acquire new HA genes so readily, why 
they have been so successful in pigs, and if they pose a further pandemic threat to 
humans. 
 
Influenza A viruses cause yearly epidemics in the human population.  Each year 
during the winter months, influenza infection causes 114,000 hospitalizations (9) and 
36,000 deaths (135) in the United States.  In the last 100 years, 4 influenza A viruses 
have emerged which caused worldwide pandemics.  A pandemic influenza virus is one 
that contains an HA to which there is little or no immunity in the population, is capable of 
sustained human-to-human transmission, and is characterized by higher than average 
morbidity worldwide (152,65).  The first criteria for the emergence of a pandemic 
influenza virus is an antigenic shift, or the introduction of a virus containing an HA to 
which the population has little or no immunity (65).  This most often occurs through 
reassortment.  Successful reassortment is dependent on four factors: infection, 
replication, packaging, and fitness.   
 
Reassortant viruses were responsible for human influenza pandemics in 1918, 
1957, and 1968, as well as the newly-emerged 2009 H1N1 pandemic (127).  The 1957 
and 1968 pandemic viruses were created through the reassortment of human and avian 
viruses, while the 1918 pandemic is now proposed to have been created through multiple 
reassortments between human, avian, and swine influenza viruses (127,33).  The 2009 
H1N1 pandemic strain is the result of a reassortment event between a North American 
triple reassortant swine virus and a Eurasian swine virus, and contains five of the six 
TRIG cassette segments (33).  While North American triple reassortant swine viruses 
have been sporadically isolated from infected humans (124), this virus was the first with 
confirmed human-to-human transmission (99). 
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One of the main determinants of the ability of an influenza virus to infect a cell is 
receptor binding.  Epithelial cells in the avian intestinal tract contain predominantly α-2,3 
linked sialyloligosaccharides, and the HAs on the surface of avian lineage influenza 
viruses preferentially recognize these receptors (52,53).  Epithelial cells in the human 
respiratory tract contain predominantly α-2,6 linked sialyloligosaccharides and the HAs 
on the surface of human lineage influenza viruses preferentially recognize these receptors 
(29,30).  Epithelial cells in the respiratory tract of pigs contain both α-2,3 and α-2,6 
linked sialyloligosaccharides, making them susceptible to infection with both avian and 
mammalian influenza viruses (52).  However, successful reassortment requires not only 
the dual infection of the same host, but co-infection of the same cell in that host.  
Although it is known that the swine respiratory tract contains both avian and human 
influenza receptors, their distribution in the respiratory tract has not been shown, and it is 
not known if they are present on the same cells.  It has been demonstrated that the human 
respiratory tract does contain cells expressing α-2,3 linked receptors, but that these cells 
are lower in the respiratory tract and are expressed by a different cell type than those that 
express the more common α-2,6 linked receptors (92).  The absence of both receptor 
linkages on the same cell does not preclude co-infection however, as growth in pigs has 
been shown to be sufficient to change the receptor specificity of an influenza virus HA 
from α-2,3 to α-2,6 (52).  It is possible that this change must occur before an avian 
influenza virus could infect the same cell as and reassort with a mammalian-origin virus. 
 
Once two viruses have infected the same cell, their genomes must both be 
replicated in order for reassortment to occur.  These studies showed that human and 
swine-origin viruses are able to replicate in pigs, and previous studies have supported 
these findings as well as demonstrating that avian viruses are also able to replicate in pigs 
(64).  While viruses of human, swine, and avian lineage are all able to replicate in pigs 
individually, it is not known if replication of one virus interferes with the replication of 
another virus in vivo.  In vitro studies showed that co-infection of MDCK cells with an 
avian virus and a classical swine virus resulted in a lack of replication of the swine 
influenza virus genome, but this effect was only observed when a very high MOI of the 
avian virus was used and both viruses were added simultaneously (118).  Neither of these 
conditions is likely to be met in vivo, and the mechanism responsible for this inhibition 
has not been determined. 
 
Following replication of the viral genomes, one of each of the eight gene 
segments of an influenza A virus must be packaged into a new virus particle.  Newly 
synthesized vRNA molecules must associate with PB2, PB1, PA, and NP for the 
formation of new vRNPs and exportation from the nucleus into the cell cytoplasm.  These 
vRNPs then interact with M1 and the cell cytoskeleton to be transported to areas of the 
membrane containing high concentrations of HA and NA proteins (103,37,12).  If any of 
these interactions are negatively impacted by the origin of the vRNA or vRNP proteins, 
then reassortment may be impaired.  The selective packaging of vRNPs into new virus 
particles is dependent on short conserved regions in the 3’ and 5’ coding regions of each 
segment (79,146,40,41).  These regions are thought to interact with each other or with 
viral proteins to allow for the selection of one copy of each gene segment (89).  Changes 
in secondary structure of the RNA or conformational changes in proteins may lead to 
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preferential packaging of gene segments from one parental strain over another, limiting 
or preventing reassortment.  Assuming two viruses of different lineages are able to infect, 
replicate in, and be packaged together into new viral particles in the same cell, reassortant 
viruses will still not be detected if the progeny virus is not more fit than the parental 
strains.  Many factors impact viral fitness, including polymerase efficiency and the ability 
of the HA to evade the host immune system (117,119,147). 
 
Comparison of triple reassortant swine viruses to double reassortant and classical 
swine viruses revealed that triple reassortant lineage viruses are less temperature sensitive 
than classical swine viruses and human viruses.  This could allow for replication in areas 
of the respiratory tract inhospitable to other swine influenza viruses and possibly increase 
the chance of replication in the same tissues as a human or avian virus.  Location of 
replication is not the sole explanation for reassortment, however, as co-infections in 
tissue culture resulted in no reassortment between classical swine and human viruses.  
Reassortant swine viruses were more efficient at establishing infection, with increased 
growth kinetics in MDCK cells at 12 hours post-infection.  They are also better able to 
establish infection in swine.  This “jump-start” in replication allows these viruses to 
outcompete non-reassortant viruses, explaining the disappearance of the classical swine 
influenza virus, and the lack of detection of wholly-avian H2 viruses in the swine 
population.  Whether the 2009 pandemic H1N1 strain replaces the currently circulating 
human epidemic strains is yet to be determined, but during the southern hemisphere flu 
season, the pandemic strain was dominant (137). 
 
The introduction of an influenza virus containing the TRIG cassette into the 
human population raises several concerns.  Epidemiological data has suggested, and this 
study has shown, that a swine virus containing the TRIG cassette has a greater 
reassortment potential than a classical swine influenza virus.  When MDCK cells were 
co-infected with a TRIG virus and a human H3N2 virus, reassortant viruses containing 
the TRIG with human HA were readily detected.  This increases the possibility of the 
introduction of multiple subtypes of HA into the swine population and possibly the 
human population.  While avian influenza viruses do not usually initiate successful 
infection in humans, they readily infect pigs (64), and the isolation in 2006 of a virus 
containing avian-origin H2 and N3 genes on the TRIG backbone has shown that TRIG 
viruses are not only able to successfully acquire mammalian-origin surface glycoproteins, 
but avian-origin HA and NA genes as well (84). 
 
After a virus with a novel HA has been created, it must be able to infect and 
transmit between humans in order to cause a pandemic.  The ability of an influenza A 
virus to successfully infect a human host is largely dependent on HA receptor specificity 
and polymerase activity.  As mentioned, the epithelial cells of the human respiratory 
epithelial tract contain predominantly α-2,6 linked receptors, so a virus containing an HA 
which preferentially binds these receptors will be more likely to infect a human than one 
containing an HA which preferentially binds α-2,3 linked receptors.  An HA with α-2,6 
receptor specificity also appears to be necessary for effective aerosol transmission of an 
influenza virus between humans, but is not sufficient to confer aerosol transmissibility to 
an avian virus (145).  In addition to receptor specificity, the viral polymerase complex 
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must be able to efficiently replicate the viral genome in a host cell.  PB2 has been shown 
to be a major host-range determinant.  Avian viruses have a conserved glutamic acid 
reside at position 627, while human viruses have a lysine (130).  Human cells have been 
shown to inhibit the activity of the polymerase complex of avian-origin viruses 
containing a glutamic acid residue at position 627 (94) and the substitution of lysine for 
glutamic acid improves the replication of avian viruses in mammalian cells (90) and 
increases the pathogenicity of highly pathogenic avian H5N1 viruses in mice (48).  
Because position 627 of PB2 is not located in a known catalytic or subunit interaction 
site, it is proposed that the mechanism controlling polymerase activity is a 
conformational change that affects interactions between the polymerase complex and the 
vRNA molecules (94).  Interestingly, the presence of a lysine residue at PB2 627 is not 
necessary for the efficient replication of avian influenza viruses in pigs, as swine 
influenza viruses have maintained a glutamic acid residue at position 627 of PB2.  
Additionally, the 2009 H1N1 pandemic strain also contains glutamic acid rather than 
lysine at position 627, indicating that other genes of the TRIG cassette may have 
compensatory changes that allow for efficient replication of the virus in humans. 
 
This study has shown that TRIG viruses are not only able to successfully acquire 
avian HA and NA genes, but also to support the adaptation of the HA receptor binding 
site from an avian-like preference to a human-like preference.  A single amino acid 
change in the receptor binding site of the HA of H2 appears to be responsible for the 
virus’s ability to transmit through direct contact in ferrets.  It is not yet known if 
SW/MO/06 is capable of aerosol transmission, or what changes might be necessary to 
confer that ability.  While an influenza virus needs to be able to transmit by aerosol to be 
a pandemic threat to the human population (65), direct contact is sufficient to allow the 
virus to spread through a swine herd, and the adaptations required to make the virus 
transmit by aerosol is still unknown.  In the case of the 1918 pandemic, only two amino 
acid changes in the HA could abolish aerosol transmission of the virus (136). 
 
The ability of viruses containing the TRIG cassette to acquire avian surface 
glycoproteins could also lead to the production of a virus containing the HA and NA 
from a highly pathogenic avian influenza virus.  Highly pathogenic H5N1 influenza 
viruses have not become successfully established in the swine or human populations (80), 
and serological studies have shown that the infection rate of swine with H5N1 viruses is 
low (24), limiting the opportunity for reassortment with a triple reassortant swine virus.  
However, now that a virus containing most of the TRIG cassette is widely circulating in 
the human population, there is the possibility of reassortment with an H5 virus in 
humans.  However, the TRIG cassette is not the only mechanism responsible for the 
success of reassortant viruses.  In the ferret model, HA greatly influenced the 
transmissibility of triple reassortant lineage viruses, with viruses containing human-origin 
HA and NA genes replicating and transmitting more efficiently than one containing 
swine-origin HA and NA genes. 
 
Although reassortment has been involved in the generation of recent pandemic 
strains, relatively little is known about the mechanisms controlling reassortment and the 
successful establishment of a new virus in a population.  There are many questions which 
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remain to be answered in order to fully understand the success of triple reassortant swine 
influenza viruses.  The TRIG cassette is a constellation of six gene segments of swine, 
human, and avian origin.  Studies are needed to determine if this specific combination of 
gene segments is required both for successful reassortment and for increased replication 
efficiency.  While viral polymerase activity has been implicated in the adaptation of avian 
viruses to mammalian hosts (42), the polymerase activity of the avian PA and PB2 in the 
TRIG cassette has not been compared to that of human or classical swine influenza 
viruses.  Additionally, while viruses containing the TRIG cassette have been shown to 
have increased fitness in cell culture, it has not been demonstrated that they have 
increased fitness in pigs, although the disappearance of the classical swine influenza 
lineage suggests reassortant viruses have an advantage over the classical swine lineage in 
vivo as well. 
 
Although epidemiological data has shown that TRIG viruses can successfully 
acquire human H1 and H3, swine H1, and avian H2 glycoproteins, it has not yet been 
determined if they are capable of acquiring HAs of other subtypes, including highly 
pathogenic H5 and H7.  Also, the virulence of such reassortant viruses could vary greatly, 
as the polymerase complex of H5N1 viruses has been shown to be partially responsible 
for their high level of pathogenicity in ferrets (119), and H5N1 viruses isolated from pigs 
have reduced virulence in mice (131).  Acquisition of a novel HA is not sufficient for the 
emergence of a new pandemic strain, as the virus must also be capable of sustained 
human to human transmission (65).  The viral adaptations necessary for aerosol 
transmission of an influenza virus in humans remain to be determined. 
 
Triple reassortant lineage influenza viruses have several unique characteristics 
which distinguishes them from other influenza A viruses.  They are highly successful at 
causing infection in swine, they are able to replicate at a broader range of temperatures in 
vitro, and they have an increased potential for acquisition of HA genes from different 
influenza viruses.  The maintenance of previously circulating human HA genes in the 
swine population also raises the possibility of the re-introduction of these viruses into the 
human population after immunity has waned.  The ease with which triple reassortant 
lineage viruses can acquire new HA genes combined with the ability of swine to act as an 
intermediate host and transmit influenza to humans highlights the need for continued 
swine influenza surveillance. 
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